
  
    
      
        Background_NNP
        Rab_NNP proteins_NNS comprise_VBP a_DT large_JJ family_NN of_IN Ras-related_NNP
        GTPases_NNP that_DT function_NN in_IN the_DT anterograde_NN and_CC retrograde_NN
        trafficking_NN of_IN proteins_NNS in_IN mammalian_JJ cells_NNS [_NN 1_CD 2_CD 3_CD ]_NN ._.
        Different_NNP Rab_NNP proteins_NNS reside_VB in_IN specific_JJ subcellular_NN
        membranes_NNS or_CC organelles_NNS ,_, where_WRB they_PRP mediate_VB vesicular_NN
        transport_NN between_IN discrete_JJ donor_NN and_CC acceptor_NN compartments_NNS
        in_IN the_DT endocytic_JJ or_CC exocytic_JJ pathways_NNS [_NN 4_CD 5_CD ]_NN ._. Detailed_NNP
        studies_NNS of_IN a_DT few_JJ Rab_NNP proteins_NNS (_( 
        e_SYM ._. g_SYM ._. ;_: Rab_NNP 1_CD ,_, Rab_NNP 5_CD and_CC Rab_NNP 9_CD )_) have_VBP led_VBN
        to_TO a_DT general_JJ model_NN wherein_WRB Rab_NNP proteins_NNS are_VBP presumed_VBN to_TO
        cycle_NN on_IN and_CC off_IN donor_NN and_CC acceptor_NN membranes_NNS in_IN connection_NN
        with_IN changes_NNS in_IN their_PRP$ guanine_NN nucleotide_NN state_NN [_NN 6_CD 7_CD 8_CD ]_NN ._.
        In_IN the_DT active_JJ GTP-bound_NNP state_NN ,_, Rab_NNP proteins_NNS associate_JJ with_IN
        budding_VBG transport_NN vesicles_NNS [_NN 9_CD 10_CD 11_CD ]_NN and_CC appear_VB to_TO
        participate_VB in_IN the_DT assembly_NN of_IN membrane_NN docking_VBG complexes_NNS [_NN
        12_CD 13_CD 14_CD ]_NN ._. Following_VBG vesicle_NN fusion_NN with_IN the_DT acceptor_NN
        compartment_NN and_CC GTP_NNP hydrolysis_NNS ,_, the_DT inactive_JJ GDP-bound_NNP Rab_NNP
        is_VBZ extracted_VBN from_IN the_DT membrane_NN by_IN a_DT carrier_NN protein_NN termed_VBD
        guanine_NN nucleotide_NN dissociation_NN inhibitor_NN (_( GDI_NNP )_) [_NN 15_CD 16_CD 17_CD
        ]_NN ._. The_DT GTPase_NNP can_MD then_RB re-enter_VB the_DT transport_NN cycle_NN
        through_IN nucleotide_NN exchange_NN promoted_VBN by_IN a_DT specific_JJ exchange_NN
        factor_NN at_IN the_DT donor_NN vesicle_NN membrane_NN [_NN 18_CD 19_CD 20_CD ]_NN ._. In_IN
        addition_NN to_TO changes_NNS in_IN guanine_NN nucleotide_NN state_NN ,_, the_DT
        posttranslational_NN prenylation_NN of_IN Rab_NNP proteins_NNS plays_VBZ an_DT
        important_JJ role_NN in_IN the_DT cycling_NN mechanism_NN ._. Non-modified_NNP Rabs_NNP
        have_VBP a_DT low_JJ affinity_NN for_IN GDI_NNP [_NN 21_CD 17_CD ]_NN and_CC do_VBP not_RB associate_JJ
        effectively_RB with_IN membranes_NNS [_NN 22_CD 23_CD ]_NN ._.
        Rab_NNP 24_CD ,_, originally_RB identified_VBN by_IN Olkkonen_NNP 
        et_CC al_NN ._. [_NN 24_CD ]_NN ,_, remains_VBZ one_CD of_IN
        several_JJ members_NNS of_IN the_DT Rab_NNP family_NN without_IN a_DT confirmed_VBN
        biological_JJ function_NN ._. We_PRP have_VBP described_VBN several_JJ unusual_JJ
        features_NNS of_IN Rab_NNP 24_CD that_WDT distinguish_VB it_PRP from_IN all_DT other_JJ
        members_NNS of_IN the_DT Rab_NNP family_NN studied_VBN to_TO date_NN [_NN 25_CD ]_NN ._. Rab_NNP 24_CD
        has_VBZ a_DT markedly_RB reduced_VBN GTPase_NNP activity_NN ,_, due_JJ primarily_RB to_TO
        the_DT presence_NN of_IN a_DT serine_NN residue_NN instead_RB of_IN the_DT usual_JJ
        glutamine_NN at_IN the_DT position_NN equivalent_JJ to_TO Q_NNP 61_CD in_IN H-R_NNP as_IN ._.
        Furthermore_RB ,_, Rab_NNP 24_CD is_VBZ not_RB efficiently_RB geranylgeranylated_JJ
        and_CC does_VBZ not_RB form_VB a_DT detectable_JJ complex_NN with_IN GDI_NNP ._. These_DT
        unique_JJ properties_NNS of_IN Rab_NNP 24_CD suggest_VBP that_IN it_PRP may_MD not_RB function_VB
        according_VBG to_TO the_DT accepted_VBD cyclical_JJ model_NN ._.
        In_IN the_DT present_JJ study_NN we_PRP set_VBD out_IN to_TO learn_VB about_IN the_DT
        biological_JJ function_NN of_IN Rab_NNP 24_CD by_IN using_VBG a_DT well-established_JJ
        paradigm_NN in_IN which_WDT a_DT dominant-negative_JJ Rab_NNP construct_VB is_VBZ
        expressed_VBN in_IN cultured_JJ cells_NNS ,_, anticipating_VBG that_IN it_PRP will_MD
        suppress_VB the_DT trafficking_NN step_NN (_( s_VBZ )_) mediated_JJ by_IN its_PRP$ endogenous_JJ
        counterpart_NN ._. Amino_NNP acid_NN substitutions_NNS at_IN the_DT position_NN
        cognate_NN to_TO N_NNP 116_CD in_IN H-R_NNP as_RB typically_RB yield_VB soluble_JJ Rab_NNP
        proteins_NNS that_WDT have_VBP a_DT reduced_VBN affinity_NN for_IN guanine_NN
        nucleotides_NNS ._. Such_JJ constructs_NNS have_VBP been_VBN used_VBN successfully_RB to_TO
        define_VB the_DT functions_NNS of_IN Rab_NNP 1_CD A_DT and_CC Rab_NNP 1_CD B_NNP [_NN 26_CD 27_CD 28_CD ]_NN ,_, Rab_NNP 4_CD
        [_NN 29_CD ]_NN ,_, Rab_NNP 5_CD [_NN 30_CD 31_CD ]_NN and_CC Rab_NNP 6_CD [_NN 32_CD ]_NN ._. Unexpectedly_NNP ,_, we_PRP
        found_VBD that_DT expression_NN of_IN the_DT mutant_JJ forms_NNS of_IN Rab_NNP 24_CD in_IN
        cultured_JJ cells_NNS resulted_VBD in_IN their_PRP$ accumulation_NN in_IN a_DT striking_JJ
        array_NN of_IN insoluble_JJ intranuclear_NN inclusions_NNS which_WDT disrupt_VB
        the_DT integrity_NN of_IN the_DT nuclear_JJ envelope_NN ._.
      
      
        Results_NNS
        
          Mutant_NNP forms_NNS of_IN Rab_NNP 24_CD accumulate_VBP in_IN nuclear_JJ
          inclusions_NNS
          In_IN all_DT of_IN the_DT known_VBN Ras-related_NNP GTPases_NNP the_DT guanine_NN
          nucleotide_NN binding_JJ site_NN is_VBZ surrounded_VBN by_IN a_DT set_NN of_IN highly_RB
          conserved_JJ sequence_NN elements_NNS [_NN 33_CD 34_CD ]_NN ._. One_CD of_IN these_DT
          elements_NNS ,_, termed_VBD the_DT G_NNP 2_CD motif_NN ,_, consists_VBZ of_IN NKxD_NNP (_( with_IN the_DT
          asparagine_NN located_VBN at_IN position_NN 116_CD in_IN H-R_NNP as_IN )_) ._. In_IN Rab_NNP 24_CD ,_,
          and_CC in_IN some_DT members_NNS of_IN the_DT Rho_NNP family_NN ,_, threonine_NN occurs_VBZ
          instead_RB of_IN the_DT asparagine_NN ._. Amino_NNP acid_NN substitutions_NNS in_IN
          the_DT N_NNP (_( T_NN )_) KxD_NNP motif_NN cause_VBP a_DT drastic_JJ reduction_NN in_IN the_DT
          affinity_NN of_IN Ras-related_NNP GTPases_NNP for_IN guanine_NN nucleotides_NNS [_NN
          35_CD 36_CD ]_NN ._. When_WRB overexpressed_JJ in_IN cultured_JJ cells_NNS ,_, these_DT
          mutant_JJ GTPases_NNP function_NN as_IN dominant-suppressors_JJ of_IN their_PRP$
          endogenous_JJ counterparts_NNS [_NN 26_CD 27_CD 31_CD ]_NN ,_, presumably_RB because_IN
          they_PRP can_MD compete_VB for_IN interaction_NN with_IN effectors_NNS ,_, exchange_NN
          factors_NNS or_CC docking_VBG proteins_NNS ,_, but_CC cannot_NN cycle_NN on_IN and_CC off_RP
          membranes_NNS in_IN a_DT nucleotide-dependent_JJ manner_NN ._. We_PRP set_VBD out_IN to_TO
          assess_VB the_DT function_NN of_IN Rab_NNP 24_CD by_IN making_VBG substitutions_NNS in_IN
          its_PRP$ TKxD_NNP motif_NN ,_, starting_VBG with_IN D_NNP 123_CD -_: -_: -_: >_NN I_PRP ._. To_TO facilitate_VB
          localization_NN of_IN the_DT proteins_NNS ,_, the_DT wild-type_JJ and_CC mutant_JJ
          constructs_NNS were_VBD made_VBN with_IN a_DT myc-epitope_JJ tag_NN at_IN the_DT amino_JJ
          terminus_JJ ._. The_DT addition_NN of_IN such_JJ tag_NN sequences_NNS to_TO
          Ras-related_NNP proteins_NNS ,_, including_VBG several_JJ members_NNS of_IN the_DT
          Rab_NNP family_NN ,_, does_VBZ not_RB appear_VB to_TO alter_VB their_PRP$ function_NN or_CC
          subcellular_NN localization_NN [_NN 36_CD 37_CD 38_CD ]_NN ._.
          When_WRB mycRab_NN 24_CD (_( wt_NN )_) was_VBD transiently_RB expressed_VBN in_IN 293_CD
          cells_NNS ,_, immunofluorescence_NN microscopy_NN revealed_VBD a_DT diffuse_NN
          reticular_NN distribution_NN throughout_IN the_DT cytoplasm_NN ,_, with_IN a_DT
          concentration_NN in_IN the_DT perinuclear_NN region_NN (_( Fig_NNP ._. 1_LS A_DT )_) ._. In_IN
          contrast_NN ,_, when_WRB the_DT same_JJ studies_NNS were_VBD performed_VBN with_IN cells_NNS
          expressing_VBG mycRab_NN 24_CD (_( D_NNP 123_CD I_PRP )_) ,_, we_PRP observed_VBD a_DT striking_JJ
          accumulation_NN of_IN the_DT mutant_JJ protein_NN in_IN punctate_NN structures_NNS
          localized_VBN in_IN both_DT cytoplasmic_JJ and_CC nuclear_JJ compartments_NNS ._.
          In_IN most_JJS cells_NNS the_DT inclusions_NNS appeared_VBD to_TO be_VB concentrated_VBN
          predominantly_RB within_IN the_DT nucleus_NN (_( Fig_NNP ._. 1_LS A_DT )_) ._. Identical_NNP
          structures_NNS were_VBD seen_VBN when_WRB immunofluorescence_NN microscopy_NN
          was_VBD performed_VBN with_IN antibodies_NNS against_IN the_DT N-_NNP terminal_NN myc_NN
          epitope_NN or_CC the_DT C-_NNP terminal_NN hypervariable_JJ domain_NN of_IN Rab_NNP 24_CD ,_,
          indicating_VBG that_IN the_DT immunofluorescence_NN pattern_NN reflected_VBD
          the_DT localization_NN of_IN full-length_JJ mycRab_NN 24_CD (_( D_NNP 123_CD I_PRP )_) ._. Finally_RB ,_,
          the_DT localization_NN pattern_NN of_IN Rab_NNP 24_CD (_( D_NNP 123_CD I_PRP )_) remained_VBD the_DT
          same_JJ when_WRB the_DT protein_NN was_VBD expressed_VBN without_IN the_DT myc_NN tag_NN
          (_( Fig_NNP ._. 1_LS B_NNP )_) ._.
          Western_JJ blot_NN analyses_NNS of_IN cytosol_NN and_CC particulate_NN
          fractions_NNS obtained_VBN from_IN the_DT transfected_JJ 293_CD cells_NNS
          indicated_VBD that_DT mycRab_NN 24_CD (_( wt_NN )_) was_VBD present_JJ in_IN both_DT
          fractions_NNS ,_, consistent_JJ with_IN previous_JJ results_NNS with_IN Rab_NNP 24_CD
          and_CC other_JJ wild-type_JJ Rab_NNP GTPases_NNP [_NN 25_CD 39_CD ]_NN ._. In_IN contrast_NN ,_,
          mycRab_NN 24_CD (_( D_NNP 123_CD I_PRP )_) was_VBD found_VBN exclusively_RB in_IN the_DT particulate_NN
          fraction_NN (_( Fig_NNP ._. 1_LS C_NNP )_) ._. When_WRB transfected_JJ cells_NNS were_VBD disrupted_VBN
          in_IN a_DT buffer_NN containing_VBG 0_CD ._. 5_CD %_NN NP-_NNP 40_CD ,_, 0_CD ._. 5_CD %_NN deoxycholate_NN and_CC
          0_CD ._. 1_CD %_NN SDS_NNP ,_, most_JJS of_IN the_DT Rab_NNP 24_CD (_( D_NNP 123_CD I_PRP )_) was_VBD recovered_VBN in_IN the_DT
          detergent-insoluble_JJ fraction_NN (_( Fig_NNP ._. 1_LS D_NNP )_) ._. This_DT suggested_VBD
          that_IN the_DT mutant_JJ protein_NN was_VBD concentrated_VBN in_IN inclusion_NN
          bodies_NNS rather_RB than_IN membrane_NN components_NNS ._.
          The_DT nuclear_JJ inclusions_NNS containing_VBG Rab_NNP 24_CD (_( D_NNP 123_CD I_PRP )_) were_VBD
          not_RB cell-type_JJ specific_NN ._. Fig_NNP ._. 2_LS Ashows_NNP that_IN similar_JJ
          punctate_NN structures_NNS were_VBD formed_VBN when_WRB the_DT D_NNP 123_CD I_PRP mutant_JJ was_VBD
          expressed_VBN in_IN NIH_NNP 3_CD T_NN 3_CD fibroblasts_NNS ._. We_PRP also_RB verified_VBN that_IN
          the_DT unique_JJ behavior_NN of_IN the_DT Rab_NNP 24_CD mutant_JJ was_VBD not_RB related_VBN
          specifically_RB to_TO the_DT substitution_NN at_IN the_DT aspartate_NN
          position_NN in_IN the_DT N_NNP (_( T_NN )_) KxD_NNP motif_NN ._. Thus_RB ,_, similar_JJ inclusions_NNS
          were_VBD observed_VBN when_WRB Rab_NNP 24_CD was_VBD expressed_VBN with_IN substitutions_NNS
          at_IN the_DT N_NNP /_NN T_NN position_NN ;_: 
          i_NNP ._. e_SYM ._. ,_, T_NN 120_CD A_DT (_( Fig_NNP ._. 2_LS A_DT )_) or_CC T_NN 120_CD I_PRP
          (_( not_RB shown_VBN )_) ._. To_TO test_VB the_DT possibility_NN that_IN protein_NN
          aggregates_NNS might_MD be_VB formed_VBN when_WRB 
          any_DT Rab_NNP GTPase_NNP is_VBZ overexpressed_JJ
          with_IN a_DT mutation_NN that_IN impairs_NNS nucleotide_NN binding_JJ ,_, we_PRP
          examined_VBD the_DT localization_NN of_IN four_CD additional_JJ members_NNS of_IN
          the_DT Rab_NNP family_NN containing_VBG amino_JJ acid_NN substitutions_NNS in_IN the_DT
          N_NNP (_( T_NN )_) KxD_NNP motif_NN ._. In_IN all_DT cases_NNS ,_, these_DT proteins_NNS exhibited_VBN a_DT
          general_JJ cytoplasmic_JJ localization_NN with_IN no_DT evidence_NN of_IN
          nuclear_JJ inclusions_NNS (_( Fig_NNP ._. 2_LS A_DT )_) ._.
          Rab_NNP 24_CD is_VBZ known_VBN to_TO be_VB expressed_VBN endogenously_RB in_IN many_JJ
          cell_NN types_NNS ,_, including_VBG the_DT cell_NN lines_NNS used_VBN in_IN these_DT
          studies_NNS [_NN 24_CD 25_CD ]_NN ,_, and_CC we_PRP have_VBP estimated_VBN that_IN both_DT
          mycRab_NN 24_CD wt_NN and_CC D_NNP 123_CD I_PRP are_VBP transiently_RB expressed_VBN 5_CD -_: 10_CD fold_VB
          over_IN the_DT level_NN of_IN endogenous_JJ Rab_NNP 24_CD (_( data_NNS not_RB shown_VBN )_) ._.
          Therefore_RB ,_, a_DT question_NN raised_VBN by_IN these_DT studies_NNS is_VBZ whether_IN
          the_DT genesis_NN of_IN nuclear_JJ inclusions_NNS occurs_VBZ indirectly_RB ,_,
          through_IN dominant_JJ suppression_NN of_IN endogenous_JJ Rab_NNP 24_CD function_NN
          by_IN the_DT D_NNP 123_CD I_PRP and_CC T_NN 120_CD A_DT mutants_NNS ,_, or_CC directly_RB ,_, through_IN
          association_NN of_IN cellular_JJ proteins_NNS with_IN the_DT accumulating_VBG
          mutant_JJ protein_NN ._. We_PRP attempted_VBD to_TO distinguish_VB between_IN these_DT
          possibilities_NNS by_IN using_VBG an_DT alternative_JJ strategy_NN to_TO make_VB a_DT
          dominant-negative_JJ form_NN of_IN Rab_NNP 24_CD ._. Several_JJ laboratories_NNS
          have_VBP shown_VBN that_IN in_IN addition_NN to_TO mutations_NNS in_IN the_DT N_NNP (_( T_NN )_) KxD_NNP
          motif_NN ,_, which_WDT reduce_VBP overall_JJ nucleotide_NN binding_JJ ,_,
          dominant-negative_JJ Rab_NNP constructs_NNS can_MD be_VB generated_VBN by_IN
          introducing_VBG amino_JJ acid_NN substitutions_NNS (_( 
          e_SYM ._. g_SYM ._. ,_, asparagine_NN )_) at_IN the_DT position_NN
          cognate_NN to_TO Ras_NNP S_NNP 17_CD (_( 
          i_NNP ._. e_SYM ._. ,_, S_NNP 22_CD in_IN Rab_NNP 24_CD )_) [_NN 31_CD 40_CD 41_CD 42_CD
          ]_NN ._. Such_JJ proteins_NNS are_VBP thought_VBN to_TO be_VB locked_VBN in_IN an_DT inactive_JJ
          GDP-bound_NNP state_NN because_IN the_DT mutation_NN markedly_RB reduces_VBZ
          their_PRP$ affinity_NN for_IN GTP_NNP ,_, compared_VBN to_TO GDP_NNP [_NN 42_CD ]_NN ._. As_IN shown_VBN
          in_IN Fig_NNP ._. 2_LS B_NNP ,_, when_WRB mycRab_NN 24_CD (_( S_NNP 22_CD N_NNP )_) was_VBD expressed_VBN in_IN 3_CD T_NN 3_CD
          cells_NNS ,_, there_EX was_VBD no_DT evidence_NN of_IN nuclear_JJ inclusions_NNS ._.
          However_RB ,_, when_WRB the_DT bound_VBN 32_CD P-_NNP labeled_VBD nucleotides_NNS
          associated_VBN with_IN the_DT expressed_VBN protein_NN were_VBD analyzed_VBN by_IN
          thin-layer_JJ chromatography_NN (_( Fig_NNP ._. 2_LS C_NNP )_) ,_, we_PRP were_VBD surprised_VBN to_TO
          find_VB that_IN the_DT S_NNP 22_CD N_NNP mutant_JJ was_VBD predominantly_RB in_IN the_DT
          GTP-bound_NNP state_NN ._. The_DT inability_NN of_IN the_DT S_NNP 22_CD N_NNP substitution_NN
          to_TO substantially_RB reduce_VB the_DT affinity_NN of_IN Rab_NNP 24_CD for_IN GTP_NNP
          adds_VBZ to_TO the_DT growing_VBG list_NN of_IN fundamental_JJ differences_NNS
          between_IN Rab_NNP 24_CD and_CC other_JJ members_NNS of_IN the_DT Rab_NNP family_NN ._. In_IN a_DT
          previous_JJ study_NN we_PRP observed_VBD that_IN replacing_VBG S_NNP 67_CD with_IN Q_NNP
          (_( which_WDT occupies_VBZ this_DT position_NN all_DT other_JJ Rab_NNP proteins_NNS )_)
          increases_VBZ the_DT GTPase_NNP activity_NN of_IN Rab_NNP 24_CD [_NN 25_CD ]_NN ,_, resulting_VBG
          in_IN a_DT modest_JJ increase_NN in_IN the_DT ratio_NN of_IN protein_NN in_IN the_DT GDP_NNP
          versus_CC GTP_NNP state_NN (_( see_VB Fig_NNP ._. 2_LS C_NNP )_) ._. When_WRB this_DT mutant_JJ was_VBD
          expressed_VBN in_IN 3_CD T_NN 3_CD cells_NNS we_PRP again_RB failed_VBD to_TO observe_VB
          inclusion_NN bodies_NNS (_( Fig_NNP ._. 2_LS B_NNP )_) ._. Since_IN neither_DT Rab_NNP 24_CD (_( S_NNP 22_CD N_NNP )_) nor_CC
          Rab_NNP 24_CD (_( S_NNP 67_CD Q_NNP )_) showed_VBD evidence_NN of_IN being_VBG locked_VBN in_IN a_DT
          GDP-bound_NNP state_NN ,_, it_PRP is_VBZ unlikely_JJ that_IN either_DT would_MD
          function_VB as_IN a_DT dominant-negative_JJ ._. Thus_RB ,_, the_DT question_NN of_IN
          whether_IN the_DT nuclear_JJ inclusions_NNS containing_VBG the_DT D_NNP 123_CD I_PRP and_CC
          T_NN 120_CD A_DT mutants_NNS are_VBP caused_VBN by_IN dominant-negative_JJ suppression_NN
          of_IN endogenous_JJ Rab_NNP 24_CD function_NN remains_VBZ to_TO be_VB resolved_VBN ._.
        
        
          Morphological_NNP characteristics_NNS of_IN the_DT nuclear_JJ
          inclusions_NNS
          Several_JJ follow-up_JJ studies_NNS supported_VBD the_DT notion_NN that_IN
          the_DT punctate_NN structures_NNS containing_VBG the_DT Rab_NNP 24_CD mutants_NNS were_VBD
          inclusion_NN bodies_NNS rather_RB than_IN membrane-bound_JJ organelles_NNS ._.
          For_IN example_NN ,_, immunofluorescence_NN microscopy_NN revealed_VBD
          little_JJ or_CC no_DT overlap_VB between_IN these_DT structures_NNS and_CC markers_NNS
          for_IN Golgi_NNP (_( Rab_NNP 6_CD ,_, 
          Lens_NNP culinaris_NNS lectin_NN )_) ,_, endosome_NN
          (_( EEA_NNP 1_LS )_) or_CC lysosome_NN (_( LAMP-_NNP 1_LS )_) membranes_NNS (_( data_NNS not_RB shown_VBN )_) ._.
          Although_IN Rab_NNP 24_CD has_VBZ been_VBN proposed_VBN as_IN a_DT possible_JJ regulator_NN
          of_IN autophagic_JJ processes_VBZ [_NN 24_CD 43_CD ]_NN ,_, the_DT accumulation_NN of_IN
          punctate_NN bodies_NNS in_IN cells_NNS expressing_VBG Rab_NNP 24_CD (_( D_NNP 123_CD I_PRP )_) was_VBD not_RB
          prevented_VBN by_IN 3_CD -_: methyadenine_NN ,_, a_DT known_VBN inhibitor_NN of_IN
          autophagosome_NN formation_NN [_NN 44_CD ]_NN ._. Most_JJS importantly_RB ,_,
          electron_NN microscopy_NN with_IN immunogold_NN labeling_VBG of_IN
          mycRab_NN 24_CD (_( D_NNP 123_CD I_PRP )_) in_IN ultra-thin_JJ sections_NNS confirmed_VBD the_DT
          initial_JJ impression_NN that_IN the_DT inclusions_NNS are_VBP in_IN fact_NN
          localized_JJ within_IN the_DT nucleus_NN ._. The_DT expressed_VBN protein_NN was_VBD
          concentrated_VBN in_IN clusters_NNS of_IN dense_JJ granules_NNS of_IN fairly_RB
          uniform_NN diameter_NN (_( 80_CD -_: 150_CD nm_NN )_) with_IN no_DT evidence_NN of_IN a_DT
          surrounding_VBG membrane_NN (_( Fig_NNP ._. 3_LS A_DT ,_, 3_CD B_NNP )_) ._. The_DT cytoplasmic_JJ
          inclusions_NNS containing_VBG mycRab_NN 24_CD (_( D_NNP 123_CD I_PRP )_) were_VBD similar_JJ to_TO
          those_DT observed_VBD inside_IN the_DT nucleus_NN ,_, except_IN that_IN they_PRP were_VBD
          larger_JJR ,_, with_IN a_DT diameter_NN 2_CD -_: 3_CD times_NNS that_IN of_IN the_DT nuclear_JJ
          particles_NNS (_( Fig_NNP ._. 3_LS D_NNP )_) ._. Such_JJ structures_NNS were_VBD never_RB observed_VBN
          in_IN cells_NNS expressing_VBG mycRab_NN 24_CD wt_NN or_CC any_DT other_JJ
          over-expressed_JJ Rab_NNP GTPase_NNP ._.
        
        
          Disruption_NNP of_IN nuclear_JJ architecture_NN by_IN inclusions_NNS
          containing_VBG Rab_NNP 24_CD (_( D_NNP 123_CD I_PRP )_)
          The_DT accumulation_NN of_IN nuclear_JJ inclusions_NNS in_IN cells_NNS
          expressing_VBG Rab_NNP 24_CD (_( D_NNP 123_CD I_PRP )_) led_VBN to_TO progressive_JJ degeneration_NN
          of_IN nuclear_JJ structure_NN ._. Figure_NN 4_CD shows_VBZ a_DT series_NN of_IN
          representative_NN photographs_NNS of_IN transfected_JJ 3_CD T_NN 3_CD cells_NNS that_WDT
          were_VBD co-stained_JJ with_IN antibody_NN against_IN the_DT Rab_NNP 24_CD myc_NN
          epitope_NN ,_, combined_VBN with_IN DAPI_NNP to_TO visualize_VB the_DT chromatin_NN
          (_( Fig_NNP ._. 4_LS A_DT )_) ,_, or_CC an_DT antibody_NN against_IN lamins_NNS A_DT and_CC B_NNP to_TO
          visualize_VB the_DT nuclear_JJ envelope_NN (_( Fig_NNP ._. 4_LS B_NNP )_) ._. At_IN 24_CD h_NN after_IN
          transfection_NN ,_, we_PRP observed_VBD many_JJ cells_NNS with_IN
          mycRab_NN 24_CD -_: positive_JJ inclusions_NNS that_WDT showed_VBD fairly_RB uniform_NN
          staining_VBG of_IN the_DT nuclear_JJ envelope_NN with_IN no_DT loss_NN of_IN
          chromatin_NN or_CC deformation_NN of_IN nuclear_JJ shape_NN ._. However_RB ,_, in_IN
          some_DT cells_NNS with_IN larger_JJR and_CC more_RBR numerous_JJ inclusions_NNS we_PRP
          observed_VBD discontinuities_NNS in_IN the_DT anti-lamin_JJ staining_VBG of_IN
          the_DT nuclear_JJ envelope_NN and_CC some_DT co-localization_JJ of_IN lamin_NN
          with_IN mycRab_NN 24_CD (_( D_NNP 123_CD I_PRP )_) in_IN the_DT intranuclear_NN aggregates_NNS ._. The_DT
          gaps_NNS in_IN the_DT nuclear_JJ membrane_NN were_VBD clearly_RB visible_JJ in_IN
          electron_NN micrographs_NNS of_IN cells_NNS with_IN large_JJ numbers_NNS of_IN
          intranuclear_NN aggregates_NNS (_( Fig_NNP ._. 3_LS C_NNP )_) ._. In_IN the_DT most_RBS extreme_JJ
          cases_NNS ,_, the_DT nuclear_JJ envelope_NN was_VBD significantly_RB distorted_JJ
          and_CC fragmented_JJ and_CC there_EX was_VBD leakage_NN of_IN chromatin_NN into_IN
          the_DT cytoplasm_NN (_( Fig_NNP ._. 4_LS A_DT &_CC 4_CD B_NNP ,_, lower_JJR panels_NNS )_) ._. The_DT number_NN
          of_IN cells_NNS with_IN obvious_JJ nuclear_JJ disruption_NN increased_VBD with_IN
          time_NN ,_, so_IN that_IN by_IN 48_CD -_: h_NN this_DT was_VBD seen_VBN in_IN the_DT majority_NN of_IN
          the_DT transfected_JJ cells_NNS (_( not_RB shown_VBN )_) ._.
          The_DT morphological_JJ changes_NNS occurring_VBG in_IN cells_NNS with_IN
          accumulated_VBN Rab_NNP 24_CD (_( D_NNP 123_CD I_PRP )_) inclusions_NNS did_VBD not_RB match_VB the_DT
          hallmark_NN features_NNS of_IN apoptosis_NNS (_( 
          e_SYM ._. g_SYM ._. ,_, membrane_NN blebbing_VBG ,_,
          condensation_NN of_IN chromatin_NN at_IN the_DT nuclear_JJ periphery_NN )_) ._. This_DT
          was_VBD confirmed_VBN by_IN TUNEL_NNP assays_NNS where_WRB cells_NNS at_IN various_JJ
          stages_NNS of_IN nuclear_JJ inclusion_NN body_NN accumulation_NN showed_VBD no_DT
          evidence_NN of_IN DNA_NNP fragmentation_NN ,_, either_CC before_IN or_CC after_IN
          disruption_NN of_IN the_DT nuclear_JJ envelope_NN (_( Fig_NNP ._. 5_LS A_DT )_) ._. In_IN
          contrast_NN ,_, TUNEL-positive_NNP cells_NNS were_VBD readily_RB detected_VBN in_IN
          parallel_JJ cultures_NNS where_WRB apoptosis_NNS was_VBD induced_VBN by_IN
          treatment_NN with_IN staurosporine_NN (_( Fig_NNP ._. 5_LS B_NNP )_) ._.
        
        
          Rab_NNP 24_CD (_( D_NNP 123_CD I_PRP )_) disrupts_NNS nuclear_JJ import_NN of_IN
          glucocorticoid_NN receptor_NN
          Rab_NNP 24_CD contains_VBZ a_DT unique_JJ arginine-rich_JJ insert_NN ,_,
          126_CD EEDRRRRR_NNP 133_CD [_NN 25_CD ]_NN in_IN the_DT domain_NN cognate_NN to_TO loop-_NN 8_CD in_IN
          H-R_NNP as_IN [_NN 34_CD ]_NN ._. The_DT latter_JJ sequence_NN is_VBZ reminiscent_NN of_IN
          unusual_JJ arginine-rich_JJ nuclear_JJ localization_NN signals_NNS that_WDT
          allow_VBP proteins_NNS like_IN HIV_NNP 
          tet_NN and_CC 
          rev_NN to_TO undergo_VB nuclear_JJ
          translocation_NN by_IN association_NN with_IN importin-β_JJ ,_, in_IN the_DT
          absence_NN of_IN importin-α_JJ [_NN 45_CD 46_CD ]_NN ._. Since_IN the_DT loop-_NN 8_CD insert_VB
          in_IN Rab_NNP 24_CD lies_VBZ adjacent_JJ to_TO the_DT conserved_JJ N_NNP (_( T_NN )_) KxD_NNP
          nucleotide_NN binding_JJ cassette_NN ,_, we_PRP hypothesized_VBN that_IN
          conformational_NN changes_NNS caused_VBN by_IN the_DT D_NNP 123_CD I_PRP substitution_NN
          might_MD render_VB the_DT Rab_NNP 24_CD mutant_JJ capable_JJ of_IN disrupting_VBG the_DT
          nuclear_JJ import_NN machinery_NN [_NN 47_CD ]_NN ._. To_TO test_VB this_DT
          possibility_NN ,_, we_PRP co-expressed_JJ mycRab_NN 24_CD wt_NN or_CC
          mycRab_NN 24_CD (_( D_NNP 123_CD I_PRP )_) with_IN GR-GFP_NNP ,_, a_DT fusion_NN between_IN the_DT
          glucocorticoid_NN receptor_NN and_CC green_JJ fluorescent_NN protein_NN ._.
          This_DT protein_NN contains_VBZ a_DT prototypical_JJ nuclear_JJ localization_NN
          signal_NN but_CC remains_VBZ in_IN the_DT cytoplasm_NN when_WRB expressed_VBD in_IN
          cultured_JJ cells_NNS in_IN the_DT absence_NN of_IN steroids_NNS ._. Upon_IN addition_NN
          of_IN 1_CD μM_NN dexamethasone_NN (_( Dex_NNP )_) the_DT receptor_NN is_VBZ translocated_JJ
          into_IN the_DT nucleus_NN within_IN 10_CD min_NN [_NN 48_CD ]_NN ._. When_WRB GR-GFP_NNP was_VBD
          co-expressed_JJ with_IN the_DT wild-type_JJ Rab_NNP 24_CD in_IN NIH_NNP 3_CD T_NN 3_CD cells_NNS ,_, we_PRP
          observed_VBD normal_JJ ligand-dependent_JJ translocation_NN of_IN GR-GFP_NNP
          into_IN the_DT nucleus_NN when_WRB Dex_NNP was_VBD applied_VBN (_( Fig_NNP ._. 6_CD A_DT )_) ._. However_RB ,_,
          when_WRB GR-GFP_NNP was_VBD coexpressed_JJ with_IN mycRab_NN 24_CD (_( D_NNP 123_CD I_PRP )_) there_EX
          was_VBD a_DT striking_JJ perturbation_NN of_IN receptor_NN localization_NN ._.
          Instead_RB of_IN remaining_VBG in_IN the_DT cytoplasm_NN in_IN the_DT absence_NN of_IN
          steroid_NN ,_, nearly_RB all_DT of_IN the_DT GR-GFP_NNP was_VBD found_VBN in_IN the_DT
          cytoplasmic_JJ and_CC nuclear_JJ inclusion_NN bodies_NNS containing_VBG the_DT
          Rab_NNP 24_CD mutant_JJ (_( Fig_NNP ._. 6_CD A_DT )_) ._. The_DT latter_JJ point_NN is_VBZ clearly_RB
          illustrated_VBN by_IN the_DT overlap_VB of_IN GR-GFP_NNP (_( green_JJ )_) fluorescence_NN
          with_IN rhodamine-_NN IgG_NNP staining_VBG for_IN mycRab_NN 24_CD (_( D_NNP 123_CD I_PRP )_) (_( red_JJ )_) in_IN
          Fig_NNP ._. 6_CD B_NNP ._. The_DT possibility_NN that_IN the_DT inclusions_NNS induced_VBN by_IN
          mycRab_NN 24_CD (_( D_NNP 123_CD I_PRP )_) contain_VB aggregated_JJ nuclear_JJ import_NN
          complexes_NNS was_VBD further_RBR supported_VBN by_IN immuno-staining_JJ with_IN
          an_DT antibody_NN against_IN importin-β_JJ (_( karyopherin-β_JJ )_) ,_, which_WDT
          revealed_VBD focal_JJ concentrations_NNS of_IN importin-β_JJ in_IN these_DT
          structures_NNS (_( Fig_NNP ._. 7_CD A_DT )_) ._. However_RB ,_, other_JJ proteins_NNS such_JJ as_IN Ran_NNP
          binding_JJ protein_NN (_( Fig_NNP ._. 7_CD B_NNP )_) and_CC Ran_NNP GAP_NNP (_( not_RB shown_VBN )_) ,_, which_WDT
          are_VBP recruited_VBN to_TO the_DT nuclear_JJ import_NN complex_JJ through_IN
          interactions_NNS with_IN the_DT Ran_NNP GTPase_NNP ,_, did_VBD not_RB appear_VB to_TO be_VB
          present_JJ in_IN the_DT inclusion_NN bodies_NNS ._.
        
        
          The_DT C-_NNP terminal_NN hypervariable_JJ domain_NN of_IN Rab_NNP 24_CD is_VBZ
          required_VBN for_IN the_DT formation_NN of_IN inclusions_NNS
          To_TO learn_VB more_JJR about_IN the_DT structural_JJ features_NNS of_IN
          Rab_NNP 24_CD (_( D_NNP 123_CD I_PRP )_) that_WDT are_VBP responsible_JJ for_IN triggering_VBG the_DT
          formation_NN of_IN nuclear_JJ inclusions_NNS ,_, we_PRP focused_VBD on_IN regions_NNS of_IN
          the_DT protein_NN that_WDT distinguish_VB Rab_NNP 24_CD from_IN other_JJ members_NNS of_IN
          the_DT Rab_NNP family_NN ._. We_PRP began_VBD by_IN deleting_VBG a_DT portion_NN of_IN the_DT
          loop-_NN 8_CD insert_VB ,_, described_VBD in_IN the_DT preceding_VBG section_NN ._. Four_CD
          amino_JJ acids_NNS (_( ΔEDRR_NN )_) were_VBD removed_VBN from_IN both_DT Rab_NNP 24_CD (_( wt_NN )_) and_CC
          Rab_NNP 24_CD (_( D_NNP 123_CD I_PRP )_) ._. Immunofluorescent_NNP localization_NN studies_NNS
          showed_VBD that_IN this_DT modification_NN had_VBD no_DT effect_NN on_IN
          distribution_NN of_IN the_DT wild-type_JJ protein_NN in_IN the_DT cytoplasm_NN
          (_( Fig_NNP ._. 8_CD A_DT )_) and_CC ,_, contrary_JJ to_TO expectations_NNS ,_, did_VBD not_RB
          interfere_VB with_IN the_DT accumulation_NN of_IN the_DT D_NNP 123_CD I_PRP mutant_JJ in_IN
          nuclear_JJ inclusions_NNS (_( Fig_NNP ._. 8_CD B_NNP )_) ._.
          The_DT second_JJ region_NN where_WRB the_DT sequence_NN of_IN Rab_NNP 24_CD differs_VBZ
          substantially_RB from_IN other_JJ Rab_NNP GTPases_NNP is_VBZ the_DT last_JJ 38_CD amino_JJ
          acids_NNS of_IN the_DT C-_NNP terminal_NN tail_NN ._. This_DT region_NN ,_, commonly_RB
          referred_VBD to_TO as_IN the_DT hypervariable_JJ domain_NN ,_, plays_VBZ a_DT major_JJ
          role_NN in_IN the_DT subcellular_NN targeting_VBG and_CC functional_JJ
          specificity_NN of_IN each_DT Rab_NNP protein_NN [_NN 49_CD ]_NN ._. In_IN accord_NN with_IN
          this_DT view_NN ,_, replacement_NN of_IN the_DT hypervariable_JJ domain_NN of_IN
          Rab_NNP 24_CD (_( wt_NN )_) with_IN the_DT corresponding_JJ domain_NN from_IN Rab_NNP 1_CD B_NNP ,_,
          caused_VBD the_DT resulting_VBG chimera_NN to_TO exhibit_VB a_DT discrete_JJ
          juxtanuclear_NN Golgi-like_NNP fluorescence_NN pattern_NN typical_JJ of_IN
          Rab_NNP 1_CD B_NNP in_IN 293_CD cells_NNS [_NN 50_CD 51_CD ]_NN ._. (_( Fig_NNP ._. 8_CD C_NNP )_) ._. When_WRB the_DT D_NNP 123_CD I_PRP
          substitution_NN was_VBD introduced_VBN into_IN the_DT Rab_NNP 24_CD portion_NN of_IN the_DT
          Rab_NNP 24_CD /_NN Rab_NNP 1_CD B_NNP chimera_NN ,_, the_DT protein_NN was_VBD no_RB longer_RB targeted_VBN
          to_TO inclusion_NN bodies_NNS (_( Fig_NNP ._. 8_CD D_NNP )_) ,_, but_CC instead_RB exhibited_VBN a_DT
          diffuse_NN distribution_NN similar_JJ to_TO Rab_NNP 1_CD B_NNP (_( N_NNP 121_CD I_PRP )_) and_CC other_JJ
          Rabs_NNP with_IN mutations_NNS in_IN the_DT N_NNP (_( T_NN )_) KxD_NNP motif_NN (_( see_VB Fig_NNP ._. 2_LS )_) ._. To_TO
          confirm_VB the_DT importance_NN of_IN the_DT Rab_NNP 24_CD hypervariable_JJ domain_NN
          for_IN targeting_VBG to_TO inclusion_NN bodies_NNS ,_, we_PRP performed_VBD the_DT
          reciprocal_JJ experiment_NN ,_, replacing_VBG the_DT C-_NNP terminal_NN domain_NN of_IN
          Rab_NNP 1_CD B_NNP (_( wt_NN )_) or_CC Rab_NNP 1_CD B_NNP (_( N_NNP 121_CD I_PRP )_) with_IN the_DT hypervariable_JJ domain_NN
          from_IN Rab_NNP 24_CD ._. Instead_RB of_IN the_DT usual_JJ Rab_NNP 1_CD B_NNP juxtanuclear_NN Golgi_NNP
          localization_NN ,_, the_DT Rab_NNP 1_CD B_NNP (_( wt_NN )_) /_NN Rab_NNP 24_CD chimera_NN showed_VBD a_DT
          broader_JJR cytoplasmic_JJ distribution_NN similar_JJ to_TO that_DT of_IN
          Rab_NNP 24_CD (_( wt_NN )_) (_( Fig_NNP ._. 8_CD E_NNP )_) ._. Most_JJS notably_RB ,_, replacement_NN of_IN
          hypervariable_JJ domain_NN of_IN Rab_NNP 1_CD B_NNP (_( N_NNP 121_CD I_PRP )_) with_IN the_DT
          corresponding_JJ C-_NNP terminal_NN region_NN from_IN Rab_NNP 24_CD caused_VBD a_DT major_JJ
          change_NN in_IN the_DT localization_NN of_IN the_DT chimera_NN from_IN a_DT
          predominant_NN cytoplasmic_JJ distribution_NN typical_JJ of_IN
          Rab_NNP 1_CD B_NNP (_( N_NNP 121_CD I_PRP )_) (_( Fig_NNP ._. 2_LS )_) to_TO a_DT pattern_NN of_IN large_JJ intranuclear_NN
          and_CC cytoplasmic_JJ inclusion_NN bodies_NNS (_( Fig_NNP ._. 8_CD F_NN )_) ._.
          To_TO determine_VB whether_IN the_DT hypervariable_JJ domain_NN of_IN Rab_NNP 24_CD
          was_VBD sufficient_JJ to_TO promote_VB the_DT formation_NN of_IN inclusion_NN
          bodies_NNS when_WRB fused_JJ to_TO a_DT heterologous_JJ protein_NN ,_, we_PRP prepared_VBD
          fusion_NN constructs_NNS with_IN enhanced_VBN green_JJ fluorescent_NN protein_NN
          (_( EGFP_NNP )_) containing_VBG either_CC full-length_JJ Rab_NNP 24_CD (_( D_NNP 123_CD I_PRP )_) or_CC just_RB
          the_DT Rab_NNP 24_CD C-_NNP terminal_NN domain_NN ._. As_IN shown_VBN in_IN Fig_NNP ._. 9_CD A_DT ,_,
          EGFP-Rab_NNP 24_CD (_( D_NNP 123_CD I_PRP )_) accumulated_VBN in_IN inclusion_NN bodies_NNS similar_JJ
          to_TO those_DT described_VBD earlier_RBR for_IN mycRab_NN 24_CD (_( D_NNP 123_CD I_PRP )_) ._. In_IN
          contrast_NN ,_, the_DT EGFP_NNP fusion_NN protein_NN containing_VBG only_RB the_DT
          hypervariable_JJ domain_NN of_IN Rab_NNP 24_CD exhibited_VBN a_DT diffuse_NN
          cytoplasmic_JJ and_CC nuclear_JJ localization_NN that_WDT was_VBD essentially_RB
          identical_JJ to_TO the_DT pattern_NN observed_VBD with_IN EGFP_NNP alone_RB (_( Fig_NNP ._.
          9_CD B_NNP &_CC 9_CD C_NNP )_) ._. Therefore_RB ,_, it_PRP appears_VBZ that_IN although_IN the_DT
          C-_NNP terminal_NN domain_NN of_IN Rab_NNP 24_CD is_VBZ required_VBN to_TO promote_VB its_PRP$
          incorporation_NN into_IN inclusion_NN bodies_NNS ,_, it_PRP does_VBZ so_RB only_RB when_WRB
          expressed_VBD in_IN the_DT context_NN of_IN a_DT Rab_NNP GTPase_NNP with_IN a_DT mutation_NN
          in_IN the_DT N_NNP (_( T_NN )_) KxD_NNP nucleotide_NN binding_JJ motif_NN ._.
        
        
          Nuclear_JJ inclusions_NNS generated_VBN by_IN Rab_NNP 24_CD (_( D_NNP 123_CD I_PRP )_)
          contain_VB ubiquitin_NN and_CC Hsp_NNP 70_CD
          Although_IN the_DT formation_NN of_IN intranuclear_NN inclusions_NNS has_VBZ
          not_RB been_VBN observed_VBN in_IN previous_JJ studies_NNS of_IN Ras-related_NNP
          GTPases_NNP ,_, it_PRP is_VBZ a_DT common_JJ feature_NN of_IN several_JJ
          neurodegenerative_JJ disorders_NNS where_WRB abnormal_JJ proteins_NNS
          containing_VBG poly-_NN Gln_NNP tracts_NNS are_VBP synthesized_JJ as_IN a_DT result_NN of_IN
          CAG_NNP codon_NN expansions_NNS [_NN 52_CD ]_NN ._. Examples_NNS include_VBP
          Huntington_NNP 's_POS disease_NN (_( huntingtin_NN )_) [_NN 53_CD 54_CD ]_NN ,_,
          spinocerebellar_NN ataxia_NN (_( SCA_NNP )_) types_NNS 1_CD and_CC 3_CD (_( ataxin-_NN 1_CD and_CC
          ataxin-_NN 3_LS )_) [_NN 55_CD 56_CD ]_NN and_CC dentatorubral-pallidoluysian_JJ
          atrophy_NN (_( atrophin-_NN 1_LS )_) [_NN 57_CD ]_NN ._. These_DT poly-_NN Gln_NNP protein_NN
          aggregates_NNS typically_RB contain_VBP ubiquitin_NN [_NN 58_CD ]_NN and_CC members_NNS
          of_IN the_DT Hsp_NNP 70_CD chaperone_NN family_NN [_NN 59_CD ]_NN ,_, consistent_JJ with_IN a_DT
          proposed_VBN pathway_NN for_IN cellular_JJ clearance_NN of_IN toxic_JJ
          misfolded_JJ proteins_NNS ._. We_PRP noted_VBD that_IN the_DT inclusions_NNS caused_VBN
          by_IN expression_NN of_IN Rab_NNP 24_CD (_( D_NNP 123_CD I_PRP )_) were_VBD similar_JJ
          morphologically_RB to_TO those_DT described_VBD in_IN some_DT of_IN the_DT
          poly-_NN Gln_NNP disorders_NNS and_CC hypothesized_VBN that_IN they_PRP might_MD arise_VB
          via_IN a_DT similar_JJ pathway_NN ._. An_DT immunofluorescence_NN study_NN was_VBD
          performed_VBN to_TO determine_VB whether_IN or_CC not_RB the_DT intranuclear_NN
          Rab_NNP 24_CD (_( D_NNP 123_CD I_PRP )_) aggregates_NNS might_MD sequester_VB ubiquitin_NN and_CC
          Hsp_NNP 70_CD ._. Both_DT ubiquitin_NN (_( Fig_NNP ._. 10_CD A_DT )_) and_CC Hsp_NNP 70_CD (_( Fig_NNP ._. 10_CD B_NNP )_)
          showed_VBD substantial_JJ overlap_VB with_IN nuclear_JJ and_CC cytoplasmic_JJ
          aggregates_NNS containing_VBG mycRab_NN 24_CD (_( D_NNP 123_CD I_PRP )_) ._. In_IN contrast_NN ,_, the_DT
          aggregates_NNS did_VBD not_RB contain_VB Hsp_NNP 90_CD (_( Fig_NNP ._. 10_CD C_NNP )_) ,_, suggesting_VBG
          that_IN the_DT sequestration_NN of_IN Hsp_NNP 70_CD was_VBD specific_JJ ._.
          To_TO determine_VB whether_IN ubiquitin_NN was_VBD conjugated_JJ directly_RB
          to_TO Rab_NNP 24_CD (_( D_NNP 123_CD I_PRP )_) ,_, it_PRP was_VBD necessary_JJ to_TO solubilize_NN the_DT
          protein_NN aggregates_NNS in_IN a_DT high-detergent_JJ buffer_NN that_WDT was_VBD
          incompatible_JJ with_IN standard_JJ immunoprecipitation_NN methods_NNS ._.
          Therefore_RB ,_, we_PRP generated_VBD a_DT mammalian_JJ expression_NN vector_NN
          encoding_VBG a_DT His_PRP$ 
          6_CD -_: tagged_VBN version_NN of_IN Rab_NNP 24_CD (_( D_NNP 123_CD I_PRP )_) and_CC
          used_VBN Ni_NNP 2_CD +_NN affinity_NN resin_NN to_TO isolate_VB the_DT expressed_VBN protein_NN
          from_IN detergent_NN extracts_NNS ._. When_WRB expressed_VBD in_IN 293_CD cells_NNS the_DT
          His_PRP$ 
          6_CD Rab_NNP 24_CD (_( D_NNP 123_CD I_PRP )_) accumulated_VBN in_IN
          inclusion_NN bodies_NNS that_WDT were_VBD morphologically_RB identical_JJ to_TO
          those_DT formed_VBN by_IN the_DT myc-tagged_JJ and_CC untagged_JJ proteins_NNS (_( not_RB
          shown_VBN )_) ._. When_WRB the_DT His_PRP$ 
          6_CD -_: tagged_VBN protein_NN was_VBD extracted_VBN from_IN
          the_DT inclusions_NNS and_CC subjected_VBN to_TO SDS-PAGE_NNP ,_, we_PRP saw_VBD no_DT
          evidence_NN of_IN higher_JJR molecular_JJ mass_NN forms_NNS that_WDT would_MD
          correspond_VB to_TO poly-ubiquitinated_JJ species_NNS ,_, using_VBG either_CC
          anti-_NN His_PRP$ 
          6_CD (_( Fig_NNP ._. 11_CD A_DT )_) or_CC anti-_NN Rab_NNP 24_CD (_( not_RB shown_VBN )_)
          antibodies_NNS ._. Moreover_RB ,_, immunoblot_NN analysis_NN of_IN the_DT His_PRP$ 
          6_CD Rab_NNP 24_CD (_( D_NNP 123_CD I_PRP )_) isolated_VBN from_IN cells_NNS
          treated_VBN with_IN lactacystin_NN (_( to_TO block_VB degradation_NN of_IN
          poly-ubiquitinated_JJ proteins_NNS by_IN the_DT 26_CD S_NNP proteasome_NN )_) showed_VBD
          no_DT detectable_JJ ubiquitin_NN associated_VBN with_IN the_DT protein_NN ,_,
          although_IN the_DT same_JJ antibody_NN detected_VBD multiple_JJ
          ubiquitinated_JJ polypeptides_NNS in_IN the_DT whole-cell_JJ lysate_NN (_( Fig_NNP ._.
          11_CD B_NNP )_) ._. Again_RB ,_, these_DT findings_NNS agree_VBP with_IN recent_JJ studies_NNS of_IN
          poly-_NN Gln_NNP protein_NN aggregates_NNS ,_, which_WDT indicate_VBP that_IN although_IN
          ubiquitinated_JJ proteins_NNS are_VBP present_JJ in_IN the_DT inclusions_NNS ,_,
          they_PRP are_VBP not_RB conjugated_JJ directly_RB to_TO the_DT initiating_VBG
          poly-_NN Gln_NNP polypeptide_NN [_NN 60_CD ]_NN ._.
        
      
      
        Discussion_NNP
        Here_RB we_PRP have_VBP shown_VBN that_IN single_JJ amino_JJ acid_NN substitutions_NNS
        (_( 
        e_SYM ._. g_SYM ._. ,_, D_NNP 123_CD I_PRP and_CC T_NN 120_CD A_DT )_) in_IN one_CD of_IN the_DT
        conserved_JJ guanine_NN nucleotide_NN binding_JJ domains_NNS of_IN Rab_NNP 24_CD can_MD
        cause_VB the_DT protein_NN to_TO accumulate_VBP in_IN a_DT massive_JJ array_NN of_IN
        nuclear_JJ inclusions_NNS in_IN mammalian_JJ cells_NNS ._. Although_IN members_NNS of_IN
        the_DT Ras_NNP GTPase_NNP superfamily_RB have_VBP been_VBN studied_VBN for_IN many_JJ years_NNS
        using_VBG site-directed_JJ mutagenesis_NNS approaches_NNS ,_, there_EX have_VBP been_VBN
        no_DT previous_JJ reports_NNS demonstrating_VBG cytopathic_JJ effects_NNS of_IN
        this_DT kind_NN ._. In_IN particular_JJ ,_, as_IN we_PRP have_VBP shown_VBN in_IN Fig_NNP ._. 2_LS ,_, a_DT
        variety_NN of_IN Rab_NNP proteins_NNS bearing_VBG similar_JJ mutations_NNS are_VBP
        localized_JJ in_IN the_DT cytoplasmic_JJ compartment_NN ._.
        It_PRP remains_VBZ unclear_JJ whether_IN the_DT nuclear_JJ inclusions_NNS
        induced_VBN by_IN Rab_NNP 24_CD (_( D_NNP 123_CD I_PRP )_) are_VBP generated_VBN 
        de_IN novo_NN inside_IN the_DT nucleus_NN or_CC instead_RB
        penetrate_VB the_DT nuclear_JJ membrane_NN after_IN being_VBG assembled_VBN in_IN the_DT
        cytoplasmic_JJ compartment_NN ._. Rab_NNP 24_CD does_VBZ not_RB have_VB a_DT classic_JJ
        nuclear_JJ localization_NN signal_NN sequence_NN ,_, but_CC monomeric_JJ
        mycRab_NN 24_CD (_( D_NNP 123_CD I_PRP )_) is_VBZ theoretically_RB small_JJ enough_RB (_( 24_CD kDa_NN )_) to_TO
        diffuse_NN across_IN the_DT nuclear_JJ pores_VBZ [_NN 61_CD ]_NN ._. However_RB ,_, it_PRP is_VBZ
        less_RBR likely_JJ that_IN this_DT could_MD occur_VB in_IN the_DT case_NN of_IN the_DT larger_JJR
        EGFP-Rab_NNP 24_CD (_( D_NNP 123_CD I_PRP )_) fusion_NN construct_VB (_( 50_CD kDa_NN )_) ,_, which_WDT also_RB
        formed_VBN abundant_JJ intranuclear_NN inclusions_NNS (_( Fig_NNP ._. 9_CD )_) ._. Our_PRP$
        preliminary_JJ observations_NNS indicate_VBP that_IN some_DT of_IN the_DT
        intranuclear_NN inclusions_NNS containing_VBG Rab_NNP 24_CD (_( D_NNP 123_CD I_PRP )_) are_VBP
        immunoreactive_JJ for_IN lamins_NNS ,_, while_IN those_DT outside_IN the_DT nucleus_NN
        are_VBP not_RB (_( Fig_NNP ._. 4_LS B_NNP )_) ._. Moreover_RB ,_, the_DT electron_NN micrographs_NNS show_VBP
        that_DT nuclei_NN containing_VBG clusters_NNS of_IN inclusions_NNS often_RB have_VBP
        regions_NNS where_WRB the_DT nuclear_JJ membrane_NN appears_VBZ to_TO be_VB
        discontinuous_JJ (_( Fig_NNP ._. 3_LS C_NNP )_) ._. Based_VBN on_IN these_DT findings_NNS ,_, we_PRP
        believe_VBP that_IN aggregates_NNS formed_VBN in_IN the_DT cytoplasm_NN may_MD
        transiently_RB associate_JJ with_IN and_CC disrupt_VB the_DT nuclear_JJ
        envelope_NN ,_, then_RB enter_VB the_DT nucleus_NN through_IN the_DT resulting_VBG
        gaps_NNS ._. Ultimately_RB ,_, the_DT accumulation_NN of_IN nuclear_JJ inclusions_NNS in_IN
        cells_NNS expressing_VBG Rab_NNP 24_CD (_( D_NNP 123_CD I_PRP )_) causes_VBZ a_DT catastrophic_JJ
        disruption_NN of_IN the_DT nuclear_JJ architecture_NN ,_, although_IN this_DT does_VBZ
        not_RB appear_VB to_TO be_VB accompanied_VBN by_IN classic_JJ signs_NNS of_IN apoptotic_JJ
        cell_NN death_NN such_JJ as_IN DNA_NNP fragmentation_NN or_CC caspase_NN
        activation_NN ._.
        The_DT molecular_JJ mechanism_NN underlying_VBG the_DT formation_NN of_IN
        nuclear_JJ inclusions_NNS in_IN cells_NNS expressing_VBG the_DT mutant_JJ forms_NNS of_IN
        Rab_NNP 24_CD remains_VBZ to_TO be_VB defined_VBN ._. An_DT extensive_JJ body_NN of_IN published_VBN
        work_NN supports_VBZ the_DT notion_NN that_IN Rab_NNP proteins_NNS bearing_NN
        mutations_NNS in_IN the_DT N_NNP (_( T_NN )_) KxD_NNP nucleotide_NN binding_JJ motif_NN function_NN
        as_IN dominant-suppressors_JJ of_IN their_PRP$ endogenous_JJ cellular_JJ
        counterparts_NNS ._. Our_PRP$ domain-exchange_JJ experiments_NNS with_IN Rab_NNP 24_CD
        and_CC Rab_NNP 1_CD B_NNP (_( Fig_NNP ._. 8_CD )_) indicate_VBP that_DT incorporation_NN of_IN the_DT
        mutant_JJ proteins_NNS into_IN nuclear_JJ inclusions_NNS requires_VBZ the_DT
        specific_JJ C-_NNP terminal_NN hypervariable_JJ targeting_VBG domain_NN of_IN
        Rab_NNP 24_CD ._. Therefore_RB ,_, one_CD possibility_NN is_VBZ that_IN the_DT inclusions_NNS
        arise_VBP as_IN a_DT consequence_NN of_IN disruption_NN of_IN the_DT normal_JJ
        physiological_JJ function_NN of_IN Rab_NNP 24_CD ._. To_TO explore_VB this_DT issue_NN
        further_RBR ,_, we_PRP attempted_VBD to_TO generate_VB another_DT potential_JJ
        dominant-negative_JJ form_NN of_IN Rab_NNP 24_CD ,_, predicted_VBD to_TO be_VB locked_VBN in_IN
        the_DT GDP_NNP state_NN ._. However_RB ,_, when_WRB we_PRP made_VBD the_DT amino_JJ acid_NN
        substitution_NN customarily_RB used_VBD to_TO generate_VB such_JJ Rab_NNP mutants_NNS
        (_( 
        i_NNP ._. e_SYM ._. ,_, S_NNP 22_CD N_NNP )_) ,_, Rab_NNP 24_CD unexpectedly_RB
        remained_VBD in_IN the_DT GTP_NNP state_NN ._. Therefore_RB ,_, pending_VBG further_RBR
        investigation_NN ,_, we_PRP cannot_NN rule_NN out_RP the_DT alternative_JJ
        hypothesis_NNS that_IN mutations_NNS in_IN the_DT N_NNP (_( T_NN )_) KxD_NNP motif_NN of_IN Rab_NNP 24_CD ,_,
        combined_VBN with_IN features_NNS in_IN the_DT C-_NNP terminal_NN domain_NN ,_, cause_VB
        Rab_NNP 24_CD to_TO misfold_NN in_IN a_DT unique_JJ manner_NN ,_, attracting_VBG
        non-physiological_JJ protein_NN partners_NNS that_WDT can_MD promote_VB
        aggregation_NN and_CC nuclear_JJ localization_NN ._.
        As_IN a_DT framework_NN for_IN future_JJ studies_NNS we_PRP can_MD envision_VB at_IN
        least_JJS three_CD models_NNS that_WDT could_MD explain_VB the_DT accumulation_NN of_IN
        inclusion_NN bodies_NNS in_IN cells_NNS expressing_VBG Rab_NNP 24_CD (_( D_NNP 123_CD I_PRP )_) ._. Our_PRP$
        immunofluorescence_NN studies_NNS (_( Fig_NNP ._. 10_CD )_) suggest_VBP that_IN the_DT
        inclusions_NNS are_VBP complex_JJ protein_NN assemblies_NNS containing_VBG Hsp_NNP 70_CD
        and_CC ubiquitin_NN ._. Therefore_RB ,_, the_DT first_JJ possibility_NN is_VBZ that_IN the_DT
        presence_NN of_IN Hsp_NNP 70_CD and_CC ubiquitin_NN reflects_VBZ a_DT failed_VBN attempt_NN
        by_IN the_DT cell_NN to_TO eliminate_VB misfolded_JJ protein_NN aggregates_NNS via_IN
        the_DT proteasome_NN pathway_NN ._. Indeed_RB ,_, a_DT similar_JJ explanation_NN has_VBZ
        been_VBN invoked_VBN to_TO explain_VB the_DT presence_NN of_IN Hsp_NNP 70_CD and_CC ubiquitin_NN
        in_IN nuclear_JJ aggregates_NNS observed_VBD in_IN cells_NNS expressing_VBG abnormal_JJ
        gene_NN products_NNS with_IN poly-_NN Gln_NNP tracts_NNS ,_, such_JJ as_IN huntingtin_NN [_NN 54_CD
        ]_NN and_CC ataxin-_NN 1_CD [_NN 59_CD ]_NN ._. Based_VBN on_IN reports_NNS that_WDT
        overexpression_NN of_IN chaperones_NNS [_NN 59_CD 62_CD ]_NN or_CC a_DT
        dominant-negative_JJ form_NN of_IN the_DT ubiquitin-conjugating_JJ enzyme_NN
        [_NN 63_CD ]_NN can_MD suppress_VB the_DT formation_NN of_IN poly-_NN Gln_NNP protein_NN
        aggregates_NNS ,_, Kaytor_NNP and_CC Warren_NNP [_NN 58_CD ]_NN proposed_VBD a_DT three-stage_JJ
        model_NN wherein_WRB (_( i_NNP )_) molecular_JJ chaperones_NNS initially_RB associate_VBP
        with_IN the_DT misfolded_JJ protein_NN ,_, (_( ii_NN )_) failure_NN to_TO diminish_VB the_DT
        pool_NN of_IN misfolded_JJ protein_NN leads_VBZ to_TO aggregation_NN and_CC
        ubiquitination_NN and_CC (_( iii_NN )_) inefficient_JJ degradation_NN of_IN the_DT
        aggregate_NN by_IN the_DT proteasome_NN is_VBZ manifested_JJ by_IN the_DT
        accumulation_NN of_IN inclusion_NN bodies_NNS ._. Although_IN this_DT model_NN
        implies_VBZ that_IN the_DT misfolded_JJ poly-_NN Gln_NNP protein_NN might_MD be_VB the_DT
        primary_JJ substrate_NN for_IN ubiquitination_NN ,_, a_DT recent_JJ study_NN by_IN
        Suhr_NNP 
        et_CC al_NN ._. [_NN 60_CD ]_NN suggests_VBZ that_IN this_DT may_MD
        not_RB always_RB be_VB the_DT case_NN ._. Specifically_RB ,_, they_PRP found_VBD that_IN when_WRB
        aggregates_NNS from_IN 293_CD cells_NNS expressing_VBG poly-_NN Gln_NNP proteins_NNS were_VBD
        dissociated_JJ ,_, the_DT ubiquitin_NN polymers_NNS were_VBD not_RB conjugated_JJ
        directly_RB to_TO the_DT poly-_NN Gln_NNP protein_NN or_CC the_DT sequestered_VBN
        Hsp_NNP 70_CD ._.
        An_DT alternative_JJ mechanism_NN for_IN the_DT formation_NN of_IN inclusion_NN
        bodies_NNS in_IN protein_NN conformation_NN disorders_NNS is_VBZ suggested_VBN by_IN a_DT
        recent_JJ study_NN showing_VBG that_DT clearance_NN of_IN poly-_NN Gln_NNP and_CC
        poly-_NN Ala_NNP inclusions_NNS is_VBZ accelerated_VBN by_IN compounds_NNS like_IN
        rapamycin_NN ,_, which_WDT stimulate_VB protein_NN degradation_NN by_IN autophagy_NN
        [_NN 64_CD ]_NN ._. Along_IN similar_JJ lines_NNS ,_, the_DT work_NN of_IN Kegel_NNP 
        et_CC al_NN ._. [_NN 65_CD ]_NN hints_NNS that_WDT poly-_NN Gln_NNP
        huntingtin_NN may_MD be_VB degraded_JJ mainly_RB in_IN autophagic_JJ vacuoles_NNS
        containing_VBG lysosomal_NN proteases_NNS ._. Interestingly_RB ,_, Rab_NNP 24_CD has_VBZ
        been_VBN implicated_VBN as_IN a_DT possible_JJ mediator_NN of_IN autophagy_NN in_IN a_DT
        recent_JJ study_NN where_WRB wild-type_JJ GFP-Rab_NNP 24_CD was_VBD observed_VBN to_TO
        accumulate_VBP on_IN large_JJ autophagic_JJ vacuoles_NNS in_IN cells_NNS subjected_VBN
        to_TO amino_JJ acid_NN starvation_NN [_NN 43_CD ]_NN ._. Thus_RB ,_, if_IN Rab_NNP 24_CD (_( D_NNP 123_CD I_PRP )_)
        functions_NNS as_IN a_DT true_JJ dominant_JJ suppressor_NN of_IN endogenous_JJ
        Rab_NNP 24_CD ,_, the_DT inclusions_NNS observed_VBD in_IN the_DT present_JJ study_NN may_MD
        consist_VB of_IN misfolded_JJ endogenous_JJ proteins_NNS that_WDT cannot_NN be_VB
        degraded_JJ because_IN basal_NN activity_NN of_IN the_DT
        autophagosome-lysosome_JJ pathway_NN is_VBZ blocked_VBN ._.
        Although_IN the_DT two_CD preceding_VBG models_NNS may_MD explain_VB the_DT
        presence_NN of_IN Hsp_NNP 70_CD and_CC ubiquitin_NN in_IN the_DT Rab_NNP 24_CD (_( D_NNP 123_CD I_PRP )_) -_: induced_VBN
        aggregates_NNS ,_, the_DT incorporation_NN of_IN glucocorticoid_NN receptor_NN
        (_( Fig_NNP ._. 6_CD )_) and_CC importin-β_JJ (_( Fig_NNP ._. 7_CD )_) may_MD point_VB to_TO a_DT third_JJ
        distinct_JJ scenario_NN ._. Aside_RB from_IN its_PRP$ well-characterized_JJ role_NN
        in_IN protein_NN folding_VBG [_NN 66_CD ]_NN ,_, Hsp_NNP 70_CD is_VBZ known_VBN to_TO associate_JJ
        with_IN the_DT GR_NNP in_IN the_DT cytoplasm_NN ,_, where_WRB it_PRP promotes_VBZ formation_NN
        of_IN a_DT heterocomplex_NN between_IN the_DT inactive_JJ GR_NNP and_CC Hsp_NNP 90_CD [_NN 67_CD ]_NN
        ._. In_IN addition_NN ,_, Hsp_NNP 70_CD becomes_VBZ concentrated_VBN in_IN the_DT nucleus_NN
        when_WRB cells_NNS are_VBP exposed_VBN to_TO environmental_JJ stress_NN [_NN 68_CD ]_NN ._. Of_IN
        particular_JJ note_NN ,_, the_DT nuclear_JJ accumulation_NN of_IN the_DT Hsp_NNP 70_CD ,_,
        Ssa_NNP 4_CD p_NN ,_, in_IN response_NN to_TO nutrient_NN deprivation_NN in_IN yeast_NN appears_VBZ
        to_TO occur_VB by_IN a_DT novel_NN mechanism_NN that_WDT involves_VBZ its_PRP$ direct_JJ
        interaction_NN with_IN Mmd_NNP 5_CD p_NN ,_, a_DT member_NN of_IN the_DT importin-β_JJ family_NN [_NN
        69_CD ]_NN ._. A_DT role_NN for_IN Rab_NNP 24_CD in_IN nuclear_JJ trafficking_NN would_MD be_VB
        unanticipated_JJ ,_, since_IN the_DT only_RB GTPase_NNP known_VBN to_TO function_VB in_IN
        nuclear_JJ import_NN /_NN export_NN (_( Ran_NNP )_) is_VBZ structurally_RB distinct_JJ from_IN
        the_DT Rab_NNP subgroup_NN of_IN the_DT Ras_NNP superfamily_RB [_NN 70_CD 71_CD ]_NN ._.
        Nevertheless_RB ,_, we_PRP can_MD speculate_VB that_IN if_IN Rab_NNP 24_CD participates_VBZ
        in_IN a_DT stress-induced_JJ pathway_NN for_IN nuclear_JJ import_NN of_IN Hsp_NNP 70_CD in_IN
        mammalian_JJ cells_NNS ,_, the_DT constitutive_JJ overexpression_NN of_IN
        Rab_NNP 24_CD (_( D_NNP 123_CD I_PRP )_) might_MD stimulate_VB aberrant_NN accumulation_NN of_IN
        Hsp_NNP 70_CD /_NN importin-β_JJ aggregates_NNS at_IN the_DT nuclear_JJ pore_NN complex_JJ ._.
        This_DT might_MD ultimately_RB result_VB in_IN disruption_NN of_IN the_DT nuclear_JJ
        envelope_NN and_CC penetration_NN of_IN the_DT aggregates_NNS into_IN the_DT
        nucleus_NN ._. If_IN the_DT Hsp_NNP 70_CD in_IN these_DT aggregates_NNS retains_VBZ the_DT
        capacity_NN to_TO bind_NN GR_NNP ,_, this_DT could_MD account_VB for_IN the_DT
        sequestration_NN of_IN nascent_NN GR_NNP in_IN these_DT structures_NNS ._.
        It_PRP is_VBZ well_RB established_VBN that_IN mutations_NNS affecting_VBG the_DT
        guanine_NN nucleotide_NN state_NN of_IN Ras_NNP are_VBP associated_VBN with_IN
        neoplastic_JJ transformation_NN of_IN mammalian_JJ cells_NNS [_NN 35_CD 72_CD 73_CD ]_NN ._.
        However_RB ,_, the_DT potential_JJ role_NN of_IN Rab_NNP mutations_NNS in_IN disease_NN is_VBZ
        just_RB beginning_VBG to_TO be_VB explored_JJ ._. Menasche_NNP 
        et_CC al_NN ._. [_NN 74_CD ]_NN found_VBD mutations_NNS in_IN the_DT
        Rab_NNP 27_CD A_DT gene_NN in_IN 16_CD patients_NNS with_IN Griscelli_NNP 's_POS syndrome_NN ,_, an_DT
        autosomal_NN recessive_JJ disorder_NN characterized_VBN by_IN defects_NNS in_IN
        skin_NN pigmentation_NN and_CC T-_NNP lymphocyte_NN and_CC macrophage_NN
        activation_NN ._. While_IN several_JJ of_IN the_DT mutations_NNS were_VBD deletions_NNS ,_,
        a_DT few_JJ were_VBD missense_NN mutations_NNS that_WDT changed_VBD single_JJ amino_JJ
        acids_NNS in_IN conserved_JJ regions_NNS of_IN the_DT Rab_NNP structure_NN ._. Mutations_NNP
        in_IN the_DT Rab_NNP 27_CD A_DT gene_NN have_VBP also_RB been_VBN detected_VBN in_IN mice_NNS with_IN the_DT
        coat_NN color_NN mutation_NN 
        ashen_NN ,_, which_WDT is_VBZ regarded_VBN as_IN a_DT model_NN
        for_IN Griscelli_NNP 's_POS syndrome_NN [_NN 75_CD 76_CD ]_NN ._. Rab_NNP 24_CD can_MD be_VB detected_VBN
        in_IN many_JJ tissues_NNS and_CC cell_NN lines_NNS [_NN 24_CD 25_CD ]_NN ,_, but_CC expression_NN
        appears_VBZ to_TO be_VB highest_JJS in_IN neuronal_NN cells_NNS [_NN 25_CD ]_NN ._. At_IN present_JJ
        there_EX are_VBP no_DT available_JJ data_NN specifically_RB linking_VBG Rab_NNP 24_CD
        mutations_NNS to_TO human_JJ disease_NN ._. However_RB ,_, there_EX are_VBP many_JJ case_NN
        reports_NNS describing_VBG patients_NNS with_IN progressive_JJ
        neurodegenerative_JJ disorders_NNS of_IN unknown_JJ etiology_NN ,_,
        collectively_RB referred_VBD to_TO as_IN neuronal_NN intranuclear_NN inclusion_NN
        disease_NN [_NN 77_CD ]_NN ._. While_IN these_DT may_MD consist_VB mainly_RB of_IN
        unidentified_JJ poly-_NN Gln_NNP or_CC poly-_NN Ala_NNP disorders_NNS ,_, the_DT present_JJ
        study_NN raises_VBZ the_DT possibility_NN that_IN some_DT forms_NNS of_IN this_DT
        disease_NN may_MD arise_VB through_IN unexpected_JJ mechanisms_NNS ,_, perhaps_RB
        involving_VBG mutations_NNS in_IN Rab_NNP 24_CD or_CC other_JJ poorly_RB characterized_VBN
        members_NNS of_IN the_DT Rab_NNP GTPase_NNP family_NN that_WDT mediate_VB trafficking_NN
        of_IN misfolded_JJ proteins_NNS within_IN autophagosomes_NNS and_CC
        lysosomes_NNS ._.
      
      
        Conclusions_NNP
        Previous_JJ studies_NNS have_VBP shown_VBN that_IN Rab_NNP 24_CD exhibits_VBZ several_JJ
        unusual_JJ characteristics_NNS that_WDT distinguish_VB it_PRP from_IN other_JJ
        members_NNS of_IN the_DT Rab_NNP GTPase_NNP family_NN [_NN 25_CD ]_NN ._. The_DT studies_NNS
        described_VBD in_IN this_DT report_NN demonstrate_VB that_IN putative_JJ
        dominant-negative_JJ mutant_JJ forms_NNS of_IN Rab_NNP 24_CD ,_, bearing_VBG single_JJ
        amino_JJ acid_NN substitutions_NNS in_IN the_DT conserved_JJ N_NNP (_( T_NN )_) KxD_NNP
        nucleotide_NN binding_JJ motif_NN (_( 
        e_SYM ._. g_SYM ._. ,_, D_NNP 123_CD I_PRP and_CC T_NN 120_CD A_DT )_) ,_, are_VBP targeted_VBN
        to_TO numerous_JJ inclusion_NN bodies_NNS that_WDT disrupt_VB the_DT nuclear_JJ
        envelope_NN and_CC enter_VB the_DT nuclear_JJ compartment_NN ._. The_DT inclusions_NNS
        bear_VBP a_DT superficial_JJ resemblance_NN to_TO those_DT described_VBD in_IN some_DT
        of_IN the_DT polyglutamine_NN disorders_NNS ,_, and_CC appear_VB to_TO sequester_VB
        Hsp_NNP 70_CD ,_, ubiquitin_NN ,_, importin-β_JJ ,_, and_CC glucocorticoid_NN receptor_NN ._.
        Studies_NNS of_IN Rab_NNP 24_CD /_NN Rab_NNP 1_CD B_NNP chimeras_NNS indicate_VBP that_IN the_DT unusual_JJ
        cytopathic_JJ effects_NNS induced_VBN by_IN the_DT D_NNP 123_CD I_PRP mutant_JJ require_VB
        sequence_NN elements_NNS within_IN the_DT Rab_NNP 24_CD C-_NNP terminal_NN hypervariable_JJ
        targeting_VBG domain_NN ._. Similar_JJ mutations_NNS in_IN the_DT N_NNP (_( T_NN )_) KxD_NNP motif_NN of_IN
        other_JJ Rab_NNP proteins_NNS typically_RB yield_VBP soluble_JJ cytoplasmic_JJ
        proteins_NNS ._. Confirmatory_NNP studies_NNS with_IN other_JJ potential_JJ
        dominant-negative_JJ mutants_NNS ,_, such_JJ as_IN those_DT bearing_NN
        substitutions_NNS at_IN the_DT position_NN cognate_NN to_TO Ras_NNP S_NNP 17_CD ,_, were_VBD not_RB
        possible_JJ with_IN Rab_NNP 24_CD ,_, because_IN such_JJ mutants_NNS remained_VBD in_IN the_DT
        GTP_NNP state_NN ._. The_DT present_JJ results_NNS further_JJ highlight_NN the_DT unique_JJ
        nature_NN of_IN Rab_NNP 24_CD and_CC raise_VB the_DT possibility_NN that_IN it_PRP may_MD
        function_VB in_IN autophagic_JJ degradation_NN of_IN misfolded_JJ proteins_NNS ,_,
        or_CC perhaps_RB play_VB an_DT unanticipated_JJ role_NN in_IN nuclear_JJ protein_NN
        trafficking_NN or_CC maintenance_NN /_NN assembly_NN of_IN the_DT nuclear_JJ
        envelope_NN ._.
      
      
        Methods_NNP
        
          Expression_NNP constructs_NNS
          The_DT cDNA_NN encoding_VBG Rab_NNP 24_CD was_VBD obtained_VBN by_IN PCR_NNP
          amplification_NN from_IN first_JJ strand_NN cDNA_NN template_NN
          reverse-transcribed_JJ from_IN mouse_NN brain_NN mRNA_NN ,_, using_VBG 
          Taq_NNP DNA_NNP polymerase_NN (_( Perkin_NNP Elmer_NNP )_) ._.
          Oligonucleotide_NNP primers_NNS for_IN the_DT PCR_NNP reaction_NN were_VBD based_VBN
          on_IN the_DT published_VBN sequence_NN of_IN murine_NN Rab_NNP 24_CD [_NN 24_CD ]_NN ._. Kpn_NNP 1_CD
          and_CC BamH_NNP 1_CD restriction_NN sites_NNS were_VBD added_VBN to_TO the_DT 5_CD '_POS and_CC 3_CD '_POS
          primers_NNS respectively_RB ,_, to_TO facilitate_VB cloning_VBG of_IN the_DT PCR_NNP
          product_NN in_IN frame_NN with_IN a_DT 5_CD '_POS sequence_NN cassette_NN encoding_VBG a_DT
          myc_NN epitope_NN (_( EQKLISEEDL_NNP )_) ,_, previously_RB introduced_VBN into_IN the_DT
          pCMV_NN 5_CD expression_NN vector_NN [_NN 78_CD ]_NN ._. The_DT Rab_NNP 24_CD cDNA_NN was_VBD
          altered_VBN by_IN overlap-extension_JJ PCR_NNP [_NN 79_CD ]_NN ,_, using_VBG
          appropriate_JJ mutator_NN oligonucleotides_NNS and_CC 
          Pfu_NNP DNA_NNP polymerase_NN (_( Stratagene_NNP
          Inc_NNP ._. ,_, La_NNP Jolla_NNP ,_, CA_NNP )_) ,_, so_RB as_IN to_TO introduce_VB amino_JJ acid_NN
          substitutions_NNS at_IN D_NNP 123_CD (_( D_NNP 123_CD I_PRP )_) ,_, T_NN 120_CD (_( T_NN 120_CD A_DT )_) ,_, S_NNP 22_CD (_( S_NNP 22_CD N_NNP )_) ,_,
          S_NNP 67_CD (_( S_NNP 67_CD Q_NNP )_) ,_, and_CC a_DT deletion_NN of_IN residues_NNS 127_CD through_IN 130_CD
          (_( ΔEDRR_NN )_) ._. The_DT cDNA_NN encoding_VBG human_JJ Rab_NNP 11_CD was_VBD obtained_VBN by_IN
          PCR_NNP amplification_NN from_IN first_JJ strand_NN cDNA_NN template_NN ,_,
          reverse-transcribed_JJ from_IN Hela_NNP cell_NN mRNA_NN ._. This_DT sequence_NN
          was_VBD cloned_VBN into_IN pCMV_NN 5_CD ,_, in-frame_JJ with_IN a_DT 5_CD '_POS myc_NN epitope_NN tag_NN
          sequence_NN ,_, and_CC altered_VBD to_TO encode_NN the_DT N_NNP 124_CD I_PRP substitution_NN as_IN
          stated_VBN above_IN for_IN Rab_NNP 24_CD ._. Other_JJ pCMV_NN 5_CD expression_NN vectors_NNS
          encoding_VBG Rab_NNP 1_CD B_NNP (_( N_NNP 121_CD I_PRP )_) [_NN 28_CD ]_NN ,_, Rab_NNP 6_CD (_( N_NNP 126_CD I_PRP )_) and_CC
          Rab_NNP 8_CD (_( N_NNP 121_CD I_PRP )_) [_NN 32_CD ]_NN have_VBP been_VBN described_VBN in_IN the_DT indicated_VBN
          references_NNS ._. pCMV_NN 5_CD expression_NN vectors_NNS containing_VBG 
          Rab_NNP 24_CD and_CC 
          Rab_NNP 1_CD B_NNP were_VBD engineered_VBN by_IN
          overlap-extension_JJ PCR_NNP to_TO encode_NN the_DT following_VBG chimeric_JJ
          proteins_NNS :_: Rab_NNP 24_CD /_NN Rab_NNP 1_CD B_NNP ,_, consisting_VBG of_IN residues_NNS 1_CD -_: 165_CD of_IN
          Rab_NNP 24_CD [_NN 24_CD ]_NN fused_JJ to_TO residues_NNS 163_CD -_: 201_CD from_IN Rab_NNP 1_CD B_NNP [_NN 80_CD ]_NN
          ;_: Rab_NNP 24_CD (_( D_NNP 123_CD I_PRP )_) /_NN Rab_NNP 1_CD B_NNP ,_, consisting_VBG of_IN residues_NNS 1_CD -_: 165_CD of_IN
          Rab_NNP 24_CD with_IN the_DT D_NNP 123_CD I_PRP substitution_NN ,_, fused_JJ to_TO residues_NNS
          163_CD -_: 201_CD of_IN Rab_NNP 1_CD B_NNP ;_: Rab_NNP 1_CD B_NNP /_NN Rab_NNP 24_CD ,_, consisting_VBG of_IN residues_NNS
          1_CD -_: 162_CD of_IN Rab_NNP 1_CD B_NNP fused_JJ to_TO residues_NNS 166_CD -_: 203_CD of_IN Rab_NNP 24_CD ;_: and_CC
          Rab_NNP 1_CD B_NNP (_( N_NNP 121_CD I_PRP )_) /_NN Rab_NNP 24_CD ,_, consisting_VBG of_IN residues_NNS 1_CD -_: 162_CD of_IN Rab_NNP 1_CD B_NNP
          with_IN the_DT N_NNP 121_CD I_PRP substitution_NN ,_, fused_JJ to_TO residues_NNS 166_CD -_: 203_CD of_IN
          Rab_NNP 24_CD ._. To_TO generate_VB Rab_NNP 24_CD fusions_NNS with_IN Enhanced_NNP Green_NNP
          Fluorescent_NNP Protein_NNP (_( EGFP_NNP )_) ,_, cDNAs_NNS encoding_VBG full-length_JJ
          Rab_NNP 24_CD (_( wt_NN )_) or_CC Rab_NNP 24_CD (_( D_NNP 123_CD I_PRP )_) ,_, or_CC the_DT Rab_NNP 24_CD C-_NNP terminal_NN
          hypervariable_JJ domain_NN (_( residues_NNS 166_CD -_: 203_CD )_) were_VBD generated_VBN
          with_IN flanking_VBG 
          KpnI_NNP and_CC 
          BamHI_NNP sites_NNS and_CC subcloned_JJ into_IN
          pEGFP-C_JJ 1_CD (_( Clontech_NNP Inc_NNP ._. ,_, Palo_NNP Alto_NNP ,_, CA_NNP )_) so_IN that_IN the_DT Rab_NNP
          inserts_NNS were_VBD in-frame_JJ with_IN a_DT 5_CD '_POS EGFP_NNP coding_VBG sequence_NN ._. The_DT
          sequences_NNS of_IN all_DT constructs_NNS were_VBD verified_VBN by_IN automated_VBN
          DNA_NNP sequencing_VBG using_VBG a_DT Beckman_NNP CEQ_NNP 2000_CD system_NN ._.
        
        
          Cell_NNP culture_NN and_CC transfection_NN
          Human_JJ embryonal_NN kidney_NN (_( HEK_NNP )_) cells_NNS (_( line_NN 293_CD )_) and_CC NIH_NNP
          3_CD T_NN 3_CD mouse_NN fibroblasts_NNS were_VBD obtained_VBN from_IN American_NNP Type_NNP
          Culture_NNP Collection_NNP (_( Rockville_NNP ,_, MD_NNP )_) and_CC were_VBD maintained_VBN at_IN
          37_CD °_NN C_NNP in_IN a_DT 5_CD %_NN CO_NNP 
          2_CD atmosphere_NN in_IN Dulbecco_NNP 's_POS modified_VBN
          Eagle_NNP 's_POS medium_NN containing_VBG 10_CD %_NN (_( v_NN /_NN v_NN )_) fetal_JJ bovine_JJ serum_NN ._.
          On_IN the_DT day_NN before_IN transfection_NN ,_, cells_NNS were_VBD plated_JJ in_IN 6_CD cm_NN
          diameter_NN dishes_NNS at_IN 5_CD ×_NN 10_CD 5_CD cells_NNS /_NN dish_NN or_CC in_IN 10_CD cm_NN
          diameter_NN dishes_NNS at_IN 2_CD ×_NN 10_CD 6_CD cells_NNS /_NN dish_NN ._. Cells_NNP were_VBD
          transfected_JJ with_IN the_DT indicated_VBN expression_NN vectors_NNS ,_, using_VBG
          Lipofectamine_NNP Plus_NNP reagent_NN (_( Life_NNP Technologies_NNPS ,_, Inc_NNP ._. ,_,
          Rockville_NNP ,_, MD_NNP )_) for_IN 293_CD cells_NNS or_CC Superfect_NNP reagent_NN
          (_( Qiagen_NNP ,_, Valencia_NNP ,_, CA_NNP )_) for_IN 3_CD T_NN 3_CD cells_NNS ,_, according_VBG to_TO the_DT
          protocols_NNS recommended_VBN by_IN the_DT manufacturers_NNS ._.
        
        
          Subcellular_NNP distribution_NN of_IN Rab_NNP 24_CD
          To_TO determine_VB the_DT subcellular_NN distribution_NN of_IN
          mycRab_NN 24_CD (_( wt_NN )_) and_CC mycRab_NN 24_CD (_( D_NNP 123_CD I_PRP )_) ,_, 293_CD cells_NNS were_VBD plated_JJ
          in_IN 10_CD cm_NN dishes_NNS and_CC transfected_JJ with_IN the_DT indicated_VBN
          expression_NN vectors_NNS ._. After_IN 24_CD h_NN ,_, the_DT cells_NNS were_VBD harvested_VBN
          in_IN PBS_NNP ,_, collected_VBN by_IN centrifugation_NN ,_, and_CC lysed_JJ in_IN 5_CD
          volumes_NNS of_IN 40_CD mM_NN Tris-_NNP HCl_NNP ,_, pH_NN 7_CD ._. 4_CD ,_, containing_VBG complete_JJ
          mini-_NN EDTA-free_NNP protease_NN inhibitor_NN cocktail_NN (_( Sigma_NNP ,_, St_NNP ._.
          Louis_NNP ,_, MO_NNP )_) ._. Soluble_NNP and_CC particulate_NN fractions_NNS were_VBD
          obtained_VBN by_IN centrifuging_VBG the_DT cell_NN lysate_NN at_IN 100_CD ,_, 000_CD ×_NN g_SYM
          for_IN 60_CD min_NN at_IN 4_CD °_NN C_NNP ._. One_CD quarter_NN of_IN each_DT fraction_NN was_VBD
          subjected_VBN to_TO SDS-PAGE_NNP and_CC immunoblot_NN analysis_NN using_VBG the_DT
          9_CD E_NNP 10_CD monoclonal_NN antibody_NN against_IN the_DT myc_NN epitope_NN
          (_( Oncogene_NNP Research_NNP Products_NNPS ,_, Cambridge_NNP ,_, MA_NNP )_) ,_, followed_VBN by_IN
          HRP-conjugated_NNP goat_NN anti-mouse_JJ IgG_NNP and_CC ECL_NNP detection_NN
          reagent_NN (_( Amersham_NNP Corp_NNP ,_, Arlington_NNP Hts_NNP ._. ,_, IL_NNP )_) as_IN described_VBN
          previously_RB [_NN 50_CD 81_CD ]_NN ._. To_TO determine_VB the_DT detergent_NN
          solubility_NN of_IN the_DT Rab_NNP 24_CD (_( D_NNP 123_CD I_PRP )_) mutant_JJ ,_, transfected_JJ cells_NNS
          from_IN a_DT 10_CD cm_NN culture_NN dish_NN were_VBD homogenized_JJ in_IN 0_CD ._. 2_CD ml_NN of_IN
          100_CD mM_NN Tris-_NNP HCl_NNP ,_, pH_NN 7_CD ._. 4_CD ,_, containing_VBG 0_CD ._. 5_CD %_NN Nonidet_NNP P-_NNP 40_CD ,_,
          0_CD ._. 5_CD %_NN sodium_NN deoxycholate_NN ,_, 0_CD ._. 1_CD %_NN SDS_NNP ,_, and_CC 2_CD mM_NN EDTA_NNP ._.
          Samples_NNP were_VBD partitioned_JJ into_IN soluble_JJ and_CC particulate_NN
          components_NNS and_CC the_DT latter_NN were_VBD subjected_VBN to_TO SDS-PAGE_NNP and_CC
          immunoblot_NN analysis_NN ._.
        
        
          Rab_NNP 24_CD guanine_NN nucleotide_NN state_NN
          To_TO assess_VB the_DT guanine_NN nucleotide_NN state_NN of_IN selected_VBN
          mycRab_NN 24_CD proteins_NNS ,_, cells_NNS were_VBD transfected_JJ with_IN the_DT
          indicated_VBN constructs_NNS and_CC incubated_JJ with_IN
          32_CD P-_NNP orthophosphate_NN for_IN 5_CD h_NN ,_, starting_VBG 24_CD h_NN after_IN
          transfection_NN ._. Radiolabeled_NNP mycRab_NN 24_CD was_VBD
          immunoprecipitated_JJ and_CC the_DT 32_CD P-_NNP labeled_VBD guanine_NN
          nucleotides_NNS eluted_JJ from_IN the_DT protein_NN were_VBD subjected_VBN to_TO
          thin-layer_JJ chromatography_NN to_TO resolve_VB GDP_NNP and_CC GTP_NNP ._.
          Aliquots_NNP of_IN the_DT immunoprecipitated_JJ protein_NN were_VBD also_RB
          subjected_VBN to_TO immunoblot_NN analysis_NN with_IN antibody_NN against_IN
          the_DT myc_NN epitope_NN ,_, so_IN that_IN the_DT amount_NN of_IN bound_VBN nucleotide_NN
          could_MD be_VB related_VBN to_TO the_DT amount_NN of_IN protein_NN ._. A_DT detailed_VBN
          description_NN of_IN these_DT procedures_NNS has_VBZ been_VBN published_VBN
          previously_RB [_NN 25_CD ]_NN ._.
        
        
          Immunofluorescence_NNP microscopy_NN
          HEK_NNP 293_CD cells_NNS or_CC NIH_NNP 3_CD T_NN 3_CD cells_NNS were_VBD seeded_VBN on_IN
          laminin-coated_JJ coverslips_NNS in_IN 60_CD mm_NN dishes_NNS and_CC transfected_JJ
          as_IN described_VBN above_IN ._. Cells_NNP were_VBD fixed_VBN for_IN 15_CD min_NN in_IN 3_CD %_NN
          (_( w_NN /_NN v_NN )_) paraformaldehyde_NN ,_, rinsed_JJ for_IN 5_CD min_NN with_IN 0_CD ._. 05_CD M_NNP NH_NNP 
          4_CD Cl_NNP 
          2_CD ,_, permeabilized_JJ for_IN 2_CD min_NN with_IN 0_CD ._. 1_CD %_NN
          (_( v_NN /_NN v_NN )_) TritonX-_NNP 100_CD ,_, and_CC blocked_VBD for_IN 30_CD min_NN with_IN 0_CD ._. 1_CD %_NN (_( w_NN /_NN v_NN )_)
          BSA_NNP ._. All_DT solutions_NNS were_VBD prepared_VBN in_IN PBS_NNP ._. To_TO detect_VB the_DT
          expressed_VBD myc-tagged_JJ Rab_NNP proteins_NNS ,_, cells_NNS were_VBD incubated_JJ
          for_IN 60_CD min_NN with_IN either_DT the_DT 9_CD E_NNP 10_CD mouse_NN monoclonal_NN antibody_NN
          against_IN the_DT myc_NN epitope_NN or_CC a_DT rabbit_NN polyclonal_NN antibody_NN
          against_IN the_DT same_JJ epitope_NN (_( Upstate_NNP Biotechnology_NNP ,_, Lake_NNP
          Placid_NNP ,_, NY_NNP )_) ._. In_IN some_DT experiments_NNS nuclei_NN were_VBD visualized_JJ
          by_IN counter-staining_JJ with_IN 4_CD '_POS ,_, 6_CD '_POS -_: diamidino-_NN 2_CD -_: phenylindole_NN
          (_( DAPI_NNP )_) (_( 2_CD μg_NN /_NN ml_NN )_) (_( Molecular_NNP Probes_NNP ,_, Eugene_NNP ,_, OR_NNP )_) ._. Other_JJ
          monoclonal_NN antibodies_NNS used_VBN in_IN combination_NN with_IN the_DT rabbit_NN
          anti-myc_JJ antibody_NN were_VBD :_: anti-lamin_JJ A_DT +_NN B_NNP and_CC
          anti-ubiquitin_JJ (_( Zymed_NNP Laboratories_NNPS ,_, South_NNP San_NNP Francisco_NNP ,_,
          CA_NNP )_) ,_, anti-_NN Hsp_NNP 70_CD and_CC anti-_NN Hsp_NNP 90_CD (_( Stressgen_NNP ,_, Inc_NNP ._. ,_,
          Victoria_NNP ,_, BC_NNP ,_, Canada_NNP )_) ,_, anti-_NN GFP_NNP (_( Clontech_NNP ,_, Inc_NNP ._. Palo_NNP
          Alto_NNP ,_, CA_NNP )_) ,_, anti-karyopherin_JJ β_NN and_CC anti-_NN Ran_NNP binding_JJ
          protein_NN (_( Transduction_NNP Laboratories_NNPS ,_, Lexington_NNP ,_, KY_NNP )_) ._.
          Depending_VBG on_IN the_DT combination_NN of_IN primary_JJ antibodies_NNS ,_, cells_NNS
          were_VBD incubated_JJ for_IN 60_CD min_NN with_IN goat_NN anti-mouse_JJ (_( GAM_NNP )_) or_CC
          goat_NN anti-rabbit_JJ (_( GAR_NNP )_) IgG_NNP 's_POS conjugated_JJ with_IN either_DT FITC_NNP
          or_CC rhodamine_NN (_( Sigma_NNP Chemical_NNP Co_NNP ._. ,_, Louis_NNP ,_, MO_NNP )_) ._.
          Photomicrographs_NNP were_VBD taken_VBN with_IN a_DT Nikon_NNP Eclipse_NNP 800_CD
          fluorescence_NN microscope_NN equipped_VBN with_IN a_DT digital_JJ camera_NN
          and_CC ImagePro_NNP software_NN (_( Media_NNP Cybernetics_NNP ,_, Silver_NNP Spring_NNP ,_,
          MD_NNP )_) ._. In_IN some_DT cases_NNS ,_, gray_JJ scale_NN images_NNS were_VBD pseudo-colored_JJ
          to_TO correspond_VB to_TO the_DT red_JJ (_( Rhodamine_NNP )_) ,_, green_JJ (_( FITC_NNP )_) or_CC
          blue_JJ (_( DAPI_NNP )_) fluorescence_NN ,_, and_CC the_DT digital_JJ images_NNS were_VBD
          merged_VBN ._.
        
        
          Nuclear_JJ translocation_NN of_IN glucocorticoid_NN
          receptor_NN
          The_DT expression_NN vector_NN pK_NN 7_CD -_: GR-GFP_NNP [_NN 48_CD ]_NN ,_, which_WDT
          encodes_NNS a_DT fusion_NN of_IN the_DT glucocorticoid_NN receptor_NN (_( GR_NNP )_) with_IN
          green_JJ fluorescent_NN protein_NN (_( GFP_NNP )_) ,_, was_VBD provided_VBN by_IN Dr_NNP ._. Ian_NNP
          Macara_NNP ,_, University_NNP of_IN Virginia_NNP ,_, Charlottesville_NNP ,_, USA_NNP ._. NIH_NNP
          3_CD T_NN 3_CD cells_NNS were_VBD seeded_VBN on_IN glass_NN coverslips_NNS in_IN DMEM_NNP
          containing_VBG 10_CD %_NN charcoal-stripped_JJ FCS_NNP ,_, without_IN phenol_NN red_JJ ._.
          Twenty_CD four_CD hours_NNS after_IN transfection_NN ,_, the_DT cells_NNS were_VBD
          changed_VBN to_TO fresh_JJ medium_NN with_IN or_CC without_IN 1_CD μM_NN
          dexamethasone_NN (_( Dex_NNP )_) ._. All_DT cells_NNS were_VBD fixed_VBN for_IN
          immunofluorescence_NN microscopy_NN 10_CD min_NN after_IN addition_NN of_IN
          Dex_NNP ._. The_DT localization_NN of_IN GR-GFP_NNP was_VBD determined_VBN in_IN
          comparison_NN to_TO mycRab_NN 24_CD ,_, detected_VBD with_IN anti-myc_JJ monoclonal_NN
          antibody_NN and_CC rhodamine-conjugated_JJ GAM-IgG_NNP ,_, as_IN described_VBN
          above_IN ._.
        
        
          Electron_NNP microscopy_NN
          Transfected_NNP cells_NNS were_VBD washed_VBN twice_RB with_IN PBS_NNP and_CC
          scraped_JJ from_IN the_DT dish_NN using_VBG a_DT rubber_NN policeman_NN ._. The_DT
          resulting_VBG cell_NN suspensions_NNS were_VBD centrifuged_JJ in_IN Eppendorf_NNP
          ®_NN tubes_NNS and_CC cell_NN pellets_NNS were_VBD fixed_VBN for_IN 5_CD min_NN at_IN room_NN
          temperature_NN using_VBG a_DT 1_CD %_NN glutaraldehyde_NN in_IN 0_CD ._. 2_CD M_NNP sodium_NN
          cacodylate_NN ,_, pH_NN 7_CD ._. 2_CD ._. Fixed_NNP cell_NN pellets_NNS were_VBD washed_VBN twice_RB
          with_IN cacodylate_NN buffer_NN and_CC twice_RB with_IN 0_CD ._. 5_CD M_NNP ammonium_NN
          chloride_NN ._. Each_DT sample_NN was_VBD dehydrated_JJ via_IN a_DT graded_JJ series_NN
          of_IN chilled_VBN ethanol_NN solutions_NNS and_CC infiltrated_VBN and_CC embedded_VBN
          in_IN LR_NNP White_NNP ®_NN Embedding_NNP media_NNS (_( London_NNP Resin_NNP Co_NNP ._. ,_, Ltd_NNP ._. ,_,
          Berkshire_NNP ,_, England_NNP )_) ,_, also_RB at_IN 2_CD °_NN C_NNP ._. Polymerized_NNP cell_NN blocks_NNS
          were_VBD ultra-thin_JJ sectioned_JJ with_IN a_DT Reichert_NNP Ultracut_NNP S_NNP
          ultramicrotome_NN (_( Leica_NNP Microsystems_NNPS ,_, Wien_NNP ,_, Austria_NNP )_) and_CC
          sections_NNS collected_VBN on_IN gold_NN 200_CD -_: mesh_VB electron_NN microscopy_NN
          support_NN grids_NNS ._. Sections_NNP were_VBD incubated_JJ with_IN PBS_NNP for_IN 5_CD
          min_NN ,_, then_RB blocked_VBN in_IN a_DT solution_NN of_IN 10_CD %_NN fish_NN gelatin_NN in_IN
          PBS_NNP for_IN 15_CD minutes_NNS ._. Reaction_NNP with_IN the_DT 9_CD E_NNP 10_CD mouse_NN anti-myc_JJ
          antibody_NN (_( 1_CD :_: 100_CD dilution_NN in_IN PBS_NNP )_) was_VBD carried_VBN out_IN for_IN 2_CD h_NN ,_,
          followed_VBN by_IN 6_CD washes_NNS with_IN PBS_NNP ._. Sections_NNP were_VBD then_RB
          incubated_JJ for_IN 1_CD h_NN with_IN GAM_NNP IgG_NNP conjugated_JJ with_IN 10_CD nm_NN
          colloidal_NN gold_NN (_( Ted_NNP Pella_NNP ,_, Inc_NNP ._. ,_, Redding_NNP ,_, CA_NNP )_) ,_, followed_VBN
          by_IN 3_CD changes_NNS of_IN PBS_NNP ._. The_DT samples_NNS were_VBD post-fixed_JJ with_IN 1_CD %_NN
          glutaraldehyde_NN and_CC stained_JJ with_IN uranyl_NN acetate_NN and_CC lead_VB
          citrate_NN ._. They_PRP were_VBD then_RB blot-dried_JJ and_CC examined_VBD with_IN a_DT
          Philips_NNP CM_NNP 10_CD transmission_NN electron_NN microscope_NN for_IN
          localization_NN of_IN the_DT colloidal_NN gold_NN probe_NN ._.
        
        
          Solubilization_NNP of_IN Rab_NNP 24_CD (_( D_NNP 123_CD I_PRP )_) from_IN inclusions_NNS and_CC
          assay_NN for_IN ubiquitination_NN
          The_DT cDNAs_NNS encoding_VBG Rab_NNP 24_CD (_( wt_NN )_) and_CC Rab_NNP 24_CD (_( D_NNP 123_CD I_PRP )_) were_VBD
          subcloned_JJ into_IN a_DT pCMV_NN 5_CD vector_NN that_WDT had_VBD been_VBN modified_VBN by_IN
          PCR_NNP to_TO encode_NN an_DT in-frame_JJ polyhistidine_NN tag_NN (_( His_PRP$ 
          6_CD )_) at_IN the_DT amino-terminus_JJ of_IN the_DT Rab_NNP
          protein_NN ._. HEK_NNP 293_CD cells_NNS grown_VBN in_IN 10_CD cm_NN diameter_NN dishes_NNS
          were_VBD transfected_JJ with_IN either_DT pCMV_NN 5_CD -_: 
          His_PRP$ 
          6_CD 
          Rab_NNP 24_CD or_CC pCMV_NN 5_CD -_: 
          His_PRP$ 
          6_CD 
          Rab_NNP 24_CD (_( D_NNP 123_CD I_PRP )_) as_IN described_VBN earlier_RBR ._.
          20_CD μM_NN lactacystin_NN (_( Sigma_NNP ,_, St_NNP ._. Louis_NNP ,_, MO_NNP )_) was_VBD added_VBN to_TO the_DT
          medium_NN 18_CD h_NN after_IN transfection_NN and_CC cells_NNS were_VBD incubated_JJ
          with_IN the_DT proteasome_NN inhibitor_NN for_IN 4_CD h_NN prior_RB to_TO harvest_NN ._.
          Cells_NNP were_VBD scraped_JJ from_IN the_DT dish_NN ,_, collected_VBN by_IN
          centrifugation_NN ,_, and_CC homogenized_JJ in_IN 0_CD ._. 25_CD ml_NN Buffer_NNP A_DT :_: 0_CD ._. 15_CD
          M_NNP NaCl_NNP ,_, 20_CD mM_NN MgCl_NNP 
          2_CD ,_, 0_CD ._. 05_CD %_NN (_( w_NN /_NN v_NN )_) SDS_NNP ,_, 20_CD mM_NN HEPES_NNP ,_, pH_NN
          7_CD ._. 4_CD ,_, supplemented_JJ with_IN protease_NN inhibitor_NN cocktail_NN ._. The_DT
          cell_NN lysate_NN was_VBD mixed_VBN with_IN 0_CD ._. 25_CD ml_NN of_IN Buffer_NNP B_NNP (_( Buffer_NNP A_DT
          containing_VBG 1_CD %_NN NP-_NNP 40_CD and_CC 1_CD %_NN deoxycholate_NN )_) and_CC the_DT
          insoluble_JJ material_NN was_VBD removed_VBN by_IN centrifugation_NN at_IN
          100_CD ,_, 000_CD ×_NN g_SYM for_IN 30_CD min_NN ._. The_DT supernatant_NN fraction_NN was_VBD
          diluted_VBN 1_CD :_: 1_CD with_IN Buffer_NNP C_NNP (_( Buffer_NNP A_DT containing_VBG 0_CD ._. 5_CD %_NN NP-_NNP 40_CD
          and_CC 0_CD ._. 5_CD %_NN deoxycholate_NN ,_, with_IN no_DT SDS_NNP )_) and_CC loaded_VBN on_IN to_TO a_DT
          Ni-_NNP NTA_NNP spin_VB column_NN (_( Qiagen_NNP )_) ._. The_DT column_NN was_VBD washed_VBN with_IN
          Buffer_NNP D_NNP (_( 0_CD ._. 15_CD M_NNP NaCl_NNP ,_, 20_CD mM_NN MgCl_NNP 
          2_CD ,_, 0_CD ._. 025_CD %_NN SDS_NNP ,_, 0_CD ._. 5_CD %_NN deoxycholate_NN ,_,
          0_CD ._. 5_CD %_NN NP-_NNP 40_CD ,_, 20_CD mM_NN HEPES_NNP ,_, pH_NN 7_CD ._. 4_LS )_) and_CC the_DT His_PRP$ 
          6_CD -_: tagged_VBN protein_NN was_VBD eluted_JJ with_IN
          Buffer_NNP D_NNP containing_VBG 0_CD ._. 25_CD M_NNP imidazole_NN ._. Samples_NNP of_IN the_DT
          eluted_JJ protein_NN were_VBD subjected_VBN to_TO SDS-PAGE_NNP and_CC immunoblot_NN
          analysis_NN as_IN described_VBN previously_RB ,_, using_VBG a_DT polyclonal_NN
          antibody_NN against_IN Rab_NNP 24_CD [_NN 25_CD ]_NN ,_, or_CC monoclonal_NN antibodies_NNS
          against_IN the_DT His_PRP$ 
          6_CD -_: tag_NN (_( Sigma_NNP )_) or_CC ubiquitin_NN (_( Zymed_NNP
          Laboratories_NNPS )_) ._.
        
        
          Cell_NNP death_NN assay_NN
          Cells_NNP were_VBD transfected_JJ with_IN pCMV_NN 5_CD expression_NN vectors_NNS
          encoding_VBG mycRab_NN 24_CD (_( D_NNP 123_CD I_PRP )_) as_IN described_VBN earlier_RBR ._. DNA_NN
          fragmentation_NN was_VBD detected_VBN by_IN terminal_NN deoxynucleotidyl_NN
          transferase-mediated_JJ dUTP_NN nick_NN end_NN labeling_VBG (_( TUNEL_NNP )_)
          assay_NN ,_, using_VBG fluorescein-_NN 12_CD -_: dUTP_NN ,_, according_VBG to_TO the_DT
          instructions_NNS supplied_VBN by_IN the_DT manufacturer_NN (_( Promega_NNP Corp_NNP ._. ,_,
          Madison_NNP ,_, WI_NNP )_) ._. Following_VBG the_DT TUNEL_NNP reaction_NN ,_, the_DT cells_NNS
          were_VBD incubated_JJ with_IN monoclonal_NN anti-myc_JJ antibody_NN and_CC
          Rhodamine-conjugated_NNP GAM_NNP IgG_NNP to_TO detect_VB the_DT expressed_VBD Rab_NNP
          protein_NN ._. Fluorescence_NNP microscopy_NN was_VBD used_VBN to_TO determine_VB
          the_DT number_NN of_IN transfected_JJ cells_NNS that_WDT were_VBD TUNEL-positive_NNP ,_,
          compared_VBN to_TO non-transfected_JJ cells_NNS in_IN the_DT same_JJ culture_NN ._. As_IN
          a_DT positive_JJ control_NN for_IN apoptosis_NNS ,_, parallel_JJ cultures_NNS were_VBD
          treated_VBN for_IN 24_CD h_NN with_IN 1_CD μM_NN staurosporine_NN ._.
        
      
      
        Authors_NNP '_'' contributions_NNS
        W_NNP ._. A_DT ._. M_NNP ._. drafted_VBD the_DT manuscript_NN and_CC supervised_VBD the_DT
        studies_NNS ._. G_NNP ._. S_NNP ._. generated_VBD the_DT Rab_NNP 24_CD constructs_NNS and_CC carried_VBD
        out_RP the_DT immunofluorescent_NN and_CC western_JJ blot_NN studies_NNS ._. W_NNP ._. G_NNP ._.
        and_CC E_NNP ._. C_NNP ._. performed_VBD the_DT immunogold_NN electron_NN microscopy_NN ._. B_NNP ._. A_DT ._.
        performed_VBD the_DT TUNEL_NNP assays_NNS ._.
      
    
  
